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ABSTRACT	  
	  
Background:	  Preimplantation	  genetic	  diagnosis	  (PGD)	  is	  technology	  by	  which	  
embryos,	  created	  through	  in	  vitro	  fertilization	  (IVF),	  can	  be	  screened	  for	  genetic	  
conditions	  or	  traits	  before	  uterine	  implantation.	  Non-­‐medical	  sex	  selection	  (NMSS)	  
describes	  the	  use	  of	  PGD	  to	  choose	  the	  sex	  of	  a	  child	  for	  social,	  rather	  than	  medical,	  
reasons.	  In	  the	  US,	  it	  is	  legal	  to	  use	  NMSS	  for	  “family	  balancing,”	  or	  the	  selection	  of	  
an	  underrepresented	  sex	  in	  a	  family.	  	  Proponents	  of	  family	  balancing	  believe	  that	  
NMSS	  is	  an	  expression	  of	  reproductive	  autonomy	  and	  is	  ethically	  acceptable	  on	  
those	  grounds.	  Opponents	  often	  cite	  beneficence,	  nonmaleficence,	  and	  justice	  as	  the	  
basis	  for	  concerns	  around	  NMSS.	  	  Physicians	  are	  thought	  of	  as	  gatekeepers	  to	  this	  
technology,	  yet	  there	  is	  little	  research	  exploring	  the	  experiences	  and	  concerns	  of	  
physicians	  around	  NMSS.	  	  
Objective:	  This	  study	  seeks	  to	  describe	  the	  experiences	  of	  healthcare	  providers	  
around	  PGD	  for	  NMSS,	  with	  a	  focus	  on	  potential	  ethical	  concerns,	  the	  decision-­‐
making	  process,	  and	  their	  views	  on	  future	  appropriate	  non-­‐medical	  uses	  of	  PGD,	  if	  
any.	  	  
Methods:	  Semi-­‐structured	  interviews	  were	  conducted	  with	  8	  OB/GYNs	  and	  6	  
reproductive	  endocrinologists	  (REs)	  currently	  practicing	  in	  the	  US.	  Interviews	  
focused	  on	  attitudes	  toward	  NMSS,	  implications	  of	  NMSS,	  decision-­‐making,	  and	  non-­‐
medical	  trait	  selection	  (NMTS).	  The	  interviews	  were	  transcribed	  and	  subjected	  to	  
thematic	  analysis	  using	  NVivo	  9.0	  qualitative	  software.	  	  
Results:	  Findings	  from	  this	  study	  reveal	  the	  nuances	  of	  physicians’	  attitudes	  toward	  
NMSS	  as	  well	  as	  the	  values	  that	  drive	  these	  attitudes.	  Analysis	  revealed	  that	  most	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physicians	  opposed	  NMSS	  but	  would	  support	  their	  patients’	  wishes	  because	  of	  the	  
principle	  of	  autonomy.	  Autonomy	  was	  also	  a	  frequent	  cause	  of	  ethical	  dilemmas	  for	  
physicians	  struggling	  with	  values.	  Not	  all	  physicians	  identified	  as	  gatekeepers	  for	  
NMSS	  technology.	  Physicians	  expressed	  conflicting	  preferences	  about	  the	  ideal	  
decision-­‐making	  process,	  indicating	  that	  they	  wanted	  professional	  societies	  to	  make	  
clear	  guidelines	  around	  NMSS,	  but	  wanting	  to	  preserve	  patient-­‐provider	  decision-­‐
making.	  Lastly,	  physicians	  were	  mostly	  opposed	  to	  non-­‐medical	  trait	  selection	  
(NMTS)	  because	  of	  interference	  in	  nature,	  parenting	  norms,	  and	  the	  importance	  of	  
valuing	  differences	  among	  people.	  
Discussion:	  Physicians	  are	  experiencing	  ethical	  dilemmas	  around	  NMSS	  and	  NMTS.	  
This	  insight	  should	  be	  used	  to	  inform	  policy	  around	  NMSS	  and	  PGD.	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RATIONALE	  AND	  BACKGROUND	  
PREIMPLANTATION	  GENETIC	  DIAGNOSIS	  
Preimplantation	  genetic	  diagnosis	  (PGD)	  is	  an	  IVF-­‐based	  technology	  that	  
allows	  embryos	  to	  be	  screened	  for	  certain	  genetic	  conditions	  prior	  to	  implantation	  
into	  a	  woman’s	  uterus.	  The	  embryos	  are	  created	  through	  in	  vitro	  fertilization	  (IVF),	  
after	  which	  one	  cell	  from	  each	  early	  embryo	  undergoes	  genetic	  testing;	  only	  
embryos	  without	  the	  genetic	  condition	  are	  implanted	  or	  frozen	  for	  later	  use.	  
Historically,	  PGD	  was	  intended	  to	  help	  at-­‐risk	  parents	  avoid	  having	  children	  affected	  
by	  monogenic,	  early-­‐onset,	  lethal	  or	  life-­‐limiting	  conditions,	  like	  Tay-­‐Sachs	  disease	  
or	  Cystic	  Fibrosis.	  PGD	  began	  in	  1992	  for	  single-­‐gene	  disorders;	  in	  2010,	  there	  were	  
50-­‐150	  genetic	  conditions	  that	  could	  be	  assessed	  by	  PGD.	  (Hershberger	  &	  Pierce,	  
2010).	  PGD	  has	  come	  to	  be	  used	  for	  adult-­‐onset	  conditions	  like	  Huntington’s	  Disease	  
or	  the	  BRCA	  mutations	  that	  predispose	  to	  Hereditary	  Breast	  and	  Ovarian	  Cancer	  
syndrome.	  PGD	  can	  also	  be	  used	  for	  medical	  sex	  selection,	  meaning	  the	  selection	  of	  
embryos	  that	  would	  be	  unaffected	  by	  a	  disease	  that	  differentially	  affects	  the	  two	  
sexes,	  such	  as	  an	  X-­‐linked	  disease.	  	  
In	  much	  the	  same	  way	  that	  the	  early	  days	  of	  IVF	  were	  fraught	  with	  
controversy	  over	  the	  wellbeing	  of	  children	  conceived	  through	  the	  technology,	  the	  
existence	  of	  PGD	  has	  renewed	  arguments	  about	  disability	  rights,	  the	  humanity	  of	  an	  
embryo,	  and	  reignited	  fears	  of	  eugenic	  potential	  (Hershberger	  &	  Pierce,	  2010).	  At	  
the	  same	  time,	  an	  expanded	  PGD	  testing	  environment	  creates	  the	  potential	  for	  
additional	  future	  uses	  of	  PGD	  and	  likely	  reflects	  an	  increasing	  acceptance	  of	  the	  
technology	  (Hershberger	  &	  Pierce,	  2010).	  Currently,	  PGD	  is	  offered	  by	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approximately	  75%	  of	  fertility	  clinics	  in	  the	  US	  (Sharp	  et	  al,	  2010)	  and	  makes	  up	  5%	  
of	  IVF	  cases	  (Winkelman	  et	  al,	  2014).	  Estimated	  usage	  ranges	  from	  3000	  to	  upward	  
of	  6000	  PGD	  procedures	  performed	  in	  the	  US	  per	  year	  (Sharp	  et	  al,	  2010;	  
Hershberger	  et	  al,	  2012).	  Exact	  numbers	  are	  difficult	  to	  obtain	  because	  there	  is	  no	  
federal	  regulation	  of	  PGD	  and	  the	  CDC	  does	  not	  require	  statistics	  on	  PGD	  use	  or	  
outcome	  (Knoppers	  et	  al,	  2006).	  
In	  addition	  to	  testing	  for	  genetic	  disorders,	  two	  more	  controversial	  uses	  of	  
PGD	  have	  emerged:	  HLA-­‐typing	  and	  non-­‐medical	  sex	  selection.	  HLA	  typing	  is	  
performed	  on	  healthy	  embryos	  to	  select	  for	  those	  who	  can	  be	  eligible	  donors	  for	  
sick	  older	  siblings	  requiring	  bone	  marrow	  transplant.	  The	  resulting	  children	  are	  
often	  termed	  “savior	  siblings”	  and	  the	  use	  of	  PGD	  for	  this	  purpose	  remains	  highly	  
controversial.	  Non-­‐medical	  sex	  selection	  (NMSS),	  the	  focus	  of	  the	  proposed	  
research,	  describes	  the	  use	  of	  sex	  selection	  techniques	  for	  any	  non-­‐clinical	  reason.	  
In	  the	  US,	  42%	  of	  137	  IVF-­‐PGD	  clinics	  surveyed	  provided	  non-­‐medical	  sex	  selection	  
(Baruch	  et	  al,	  2008).	  NMSS	  is	  the	  first	  non-­‐medical	  use	  of	  this	  powerful	  technology,	  
making	  it	  a	  target	  for	  medical	  ethics	  concerns	  and	  uncertainty	  about	  its	  current	  
capabilities,	  level	  of	  social	  acceptance,	  as	  well	  as	  future	  potential	  uses	  and	  their	  
implications.	  
	  
PGD	  AND	  SEX	  SELECTION	  
Sex	  selection	  refers	  to	  the	  process	  by	  which	  one	  attempts	  to	  choose	  the	  sex	  of	  
their	  offspring.	  Currently,	  there	  are	  two	  main	  methods	  of	  sex	  selection:	  pre-­‐
implantation	  genetic	  diagnosis	  (PGD)	  and	  non-­‐invasive	  prenatal	  testing	  (NIPT)	  or	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sonogram	  followed	  by	  pregnancy	  termination	  (prenatal	  sex	  selection)	  (Levy,	  2007).	  	  
This	  research	  chooses	  to	  focus	  on	  sex	  selection	  through	  PGD	  only.	  Neither	  the	  
Centers	  for	  Disease	  Control	  (CDC)	  nor	  the	  Society	  of	  Assisted	  Reproductive	  
Technology	  (SART)	  includes	  the	  number	  of	  IVF	  cycles	  in	  which	  PGD	  for	  sex	  selection	  
was	  performed,	  making	  the	  number	  of	  individuals	  seeking	  or	  using	  sex	  selection	  in	  
the	  US	  difficult	  to	  estimate	  (Puri	  &	  Nachtigall,	  2010).	  Despite	  this,	  recent	  research	  
suggests	  that	  demand	  for	  sex	  selection	  seems	  to	  be	  increasing	  as	  it	  becomes	  more	  
widely	  available	  and	  more	  publicized	  (Puri	  &	  Nachtigall,	  2010).	  	  
Non-­‐medical	  sex	  selection	  (NMSS)	  describes	  sex	  selection	  for	  social,	  cultural,	  
personal,	  or	  any	  other	  non-­‐clinical	  reasons.	  Medical	  sex	  selection	  is	  generally	  well-­‐
accepted	  among	  the	  medical	  and	  non-­‐scientific	  communities	  whereas	  NMSS	  is	  often	  
perceived	  as	  controversial.	  Family	  balancing	  is	  one	  iteration	  of	  non-­‐medical	  sex	  
selection.	  Family	  balancing	  refers	  to	  the	  selection	  of	  fetal	  sex	  to	  provide	  a	  couple	  
with	  a	  child	  of	  the	  sex	  that	  is	  not	  represented	  or	  underrepresented	  in	  the	  family.	  The	  
concept	  stands	  in	  contrast	  to	  the	  use	  of	  the	  NMSS	  to	  select	  the	  sex	  of	  one’s	  first	  child.	  
Fertility	  centers	  in	  the	  US	  offer	  family	  balancing,	  though	  most	  will	  not	  provide	  NMSS	  
for	  a	  couple’s	  first	  child	  (Genetics	  &	  IVF	  Institute;	  New	  Jersey	  Fertility	  Center).	  The	  
policy	  on	  not	  providing	  NMSS	  for	  the	  first	  child	  comes	  from	  the	  official	  ASRM	  
guidelines	  that,	  though	  not	  law,	  are	  generally	  respected	  by	  fertility	  clinics	  and	  other	  
institutions	  (Ethics	  Committee	  of	  the	  American	  Society	  for	  Reproductive	  Medicine,	  
2001).	  	  Another	  sex	  selection	  technique,	  sperm	  sorting,	  is	  less	  accurate	  than	  PGD,	  
but	  also	  less	  expensive	  and	  less	  invasive.	  However,	  as	  of	  March	  2012,	  MicroSort,	  the	  
most	  accurate	  sperm	  sorting	  technology,	  is	  no	  longer	  available	  in	  the	  US	  for	  any	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reason.	  In	  April	  of	  2011,	  the	  FDA	  stopped	  enrollment	  of	  couples	  seeking	  NMSS	  
through	  MicroSort	  citing	  “no	  public	  health	  benefit”	  (Dahl,	  2011).	  	  	  	  	  
	  
Regulation	  and	  Legislation	  
In	  the	  United	  States,	  there	  is	  no	  federal	  regulation	  of	  PGD	  and,	  though	  many	  
states	  have	  legislation	  around	  IVF,	  none	  had	  addressed	  PGD	  by	  2006.	  The	  American	  
Society	  for	  Reproductive	  Medicine	  (ASRM)	  has	  guidelines	  discouraging	  PGD	  for	  sex	  
selection,	  however	  membership	  in	  ASRM	  is	  not	  compulsory	  nor	  can	  ASRM	  enforce	  
its	  guidelines.	  Some	  physicians	  may,	  therefore,	  be	  concerned	  about	  the	  possibility	  of	  
abuse	  of	  the	  technology	  in	  the	  absence	  of	  regulation	  (Knoppers	  et	  al,	  2006).	  PGD-­‐
related	  legislation	  is	  difficult	  to	  conceptualize	  because	  “moral	  legislation”	  is	  often	  
perceived	  to	  be	  in	  conflict	  with	  constitutional	  rights.	  Physicians	  would	  likely	  be	  
concerned	  that	  any	  legislation	  would	  have	  to	  take	  care	  not	  to	  obstruct	  individuals’	  
constitutional	  rights,	  especially	  those	  relating	  to	  reproductive	  autonomy.	  Physicians	  
are	  more	  likely	  to	  endorse	  self-­‐regulation	  by	  relevant	  professional	  societies,	  rather	  
than	  state	  or	  federal-­‐level	  legislation	  (Knoppers	  et	  al,	  2006).	  
As	  of	  2006,	  PGD	  was	  permitted	  by	  law	  in	  about	  a	  dozen	  countries,	  
permissible	  under	  professional	  guidelines	  in	  about	  five,	  and	  prohibited	  in	  
approximately	  five.	  Approximately	  16	  countries	  allow	  sex	  selection	  via	  PGD	  for	  
“medical	  reasons”,	  but	  not	  for	  “cultural”	  reasons	  or	  “family	  balancing,”	  the	  latter	  
being	  references	  to	  non-­‐medical	  sex	  selection.	  (Knoppers	  et	  al,	  2006).	  As	  of	  2012,	  no	  
country	  explicitly	  permits	  sex	  selection.	  Five	  countries	  prohibit	  sex	  selection	  for	  any	  
reason	  and	  31	  prohibit	  it	  for	  social	  or	  non-­‐medical	  uses.	  Many	  countries	  do	  not	  have	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laws	  or	  policies	  regarding	  sex	  selection;	  the	  US,	  for	  example,	  does	  not	  have	  an	  
official	  policy	  on	  sex	  selection.	  Israel	  allows	  NMSS	  when	  a	  family	  has	  at	  least	  four	  
children	  of	  one	  sex	  (Aghajanova	  &	  Valdes,	  2012).	  The	  Genetics	  and	  Public	  Policy	  
Center	  (GPPC)	  survey	  showed	  that	  61%	  of	  Americans	  support	  safety	  and	  efficacy	  
regulation	  of	  PGD	  and	  37%	  desire	  some	  regulation	  based	  on	  moral	  grounds.	  Of	  note:	  
20%	  of	  Americans	  surveyed	  favored	  an	  outright	  ban	  on	  the	  technology.	  In	  this	  same	  
survey,	  however,	  40%	  of	  Americans	  supported	  the	  use	  of	  PGD	  for	  sex	  selection.	  
(Knoppers	  et	  al,	  2006).	  
	  
Guidelines:	  ASRM	  and	  ACOG	  
In	  its	  2001	  report	  on	  “Preconception	  Gender	  Selection	  for	  Nonmedical	  Reasons,”	  
the	  Ethics	  Committee	  of	  the	  American	  Society	  for	  Reproductive	  Medicine	  (ASRM)	  
acknowledges	  that	  gender	  selection,	  by	  one	  method	  or	  another,	  has	  been	  occurring	  
for	  centuries.	  Of	  importance	  to	  the	  ASRM	  is	  that	  attention	  is	  paid	  to	  ethical	  and	  
social	  concerns	  of	  the	  practice	  before	  Assisted	  Reproductive	  Technology	  (ART)	  is	  
widely	  available	  for	  non-­‐medical	  use.	  After	  discussing	  the	  ethical	  arguments	  on	  both	  
sides	  of	  the	  debate,	  their	  relative	  importance,	  and	  their	  implications,	  the	  ASRM	  
offers	  four	  recommendations:	  1)	  couples	  must	  receive	  counseling	  about	  the	  risks	  of	  
failure;	  2)	  couples	  must	  affirm	  they	  will	  accept	  a	  child	  of	  the	  opposite	  sex;	  3)	  couples	  
must	  be	  counseled	  about	  unrealistic	  expectations	  around	  gender	  roles	  and	  
behavior;	  and	  4)	  couples	  should	  be	  given	  the	  opportunity	  to	  participate	  in	  relevant	  
research.	  Ultimately,	  the	  ASRM	  concludes:	  “Practitioners	  offering	  assisted	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reproductive	  services	  are	  under	  no	  legal	  or	  ethical	  obligation	  to	  provide	  
nonmedically	  indicated	  preconception	  methods	  of	  gender	  selection.”	  	  
Later,	  in	  a	  2004	  report	  on	  “Sex	  Selection	  and	  Preimplantation	  Genetic	  
Diagnosis,”	  the	  committee	  reviews	  arguments	  for	  and	  against	  sex	  selection,	  re-­‐
addresses	  ethical	  concerns,	  and	  concludes	  that	  1)	  only	  medical	  uses	  of	  sex	  selection	  
override	  the	  aforementioned	  ethical	  and	  societal	  concerns;	  2)	  non-­‐medical	  sex	  
selection	  is	  not	  currently	  harmful	  enough	  to	  warrant	  blanket	  prohibition;	  3)	  PGD	  
during	  IVF	  should	  not	  be	  encouraged;	  and	  4)	  PGD	  in	  the	  absence	  of	  the	  need	  for	  IVF	  
should	  be	  discouraged.	  The	  report	  ended	  with	  a	  call	  for	  the	  study	  of	  the	  
consequences	  of	  the	  practice	  of	  non-­‐medical	  sex	  selection.	  
	   In	  2007,	  the	  Ethics	  Committee	  of	  the	  American	  College	  of	  Obstetrics	  and	  
Gynecology	  (ACOG)	  issued	  a	  Committee	  Opinion	  with	  a	  stricter	  stance	  on	  NMSS	  than	  
that	  of	  the	  ASRM.	  The	  report	  says	  “the	  committee	  rejects	  the	  position	  that	  sex	  
selection	  should	  be	  performed	  on	  demand	  because	  this	  position	  may	  reflect	  and	  
encourage	  sex	  discrimination.”	  Like	  ASRM,	  the	  committee	  found	  the	  use	  of	  sex	  
selection	  to	  prevent	  sex-­‐linked	  genetic	  disorders	  to	  be	  ethically	  permissible,	  but	  
opposed	  meeting	  other	  requests	  for	  sex	  selection	  “for	  personal	  and	  family	  reasons,	  
including	  family	  balancing,	  because	  of	  the	  concern	  that	  such	  requests	  may	  
ultimately	  support	  sexist	  practices.”	  
	  
NON-­MEDICAL	  SEX	  SELECTION:	  TRENDS,	  CONTROVERSY,	  AND	  PUBLIC	  
OPINION	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A	  recent	  study	  found	  that	  9%	  of	  PGD	  performed	  in	  the	  US	  was	  performed	  for	  
non-­‐medical	  reasons	  (Klitzman,	  2008).	  In	  an	  internet	  survey	  of	  1,197	  Americans	  
(ages	  18-­‐45),	  8%	  of	  respondents	  claimed	  they	  would	  use	  preconception	  sex	  
selection	  services,	  whereas	  a	  study	  of	  women	  undergoing	  IVF	  found	  that	  40.8%	  
would	  select	  the	  child’s	  sex	  if	  it	  was	  an	  add-­‐on	  service	  free	  of	  charge	  (Puri	  &	  
Nachtigall,	  2010).	  Additionally,	  the	  Society	  for	  Assisted	  Reproductive	  Technology	  
reported	  that	  use	  of	  IVF-­‐PGD	  for	  non-­‐medical	  sex	  selection	  increased	  from	  2007	  to	  
2008	  by	  over	  5%	  (Ginsburg	  et	  al.	  2011).	  These	  reports	  suggest	  that,	  despite	  
professional	  recommendations	  to	  the	  contrary	  (Ethics	  Committee	  of	  the	  American	  
Society	  for	  Reproductive	  Medicine	  1999),	  sex	  selection	  via	  IVF-­‐PGD	  is	  available	  and	  
incidence	  may	  be	  increasing	  in	  the	  US,	  though	  overall	  incidence	  is	  still	  infrequent	  
(McGowan	  &	  Sharp,	  2013).	  	  
	  
Sex,	  Gender,	  and	  Family	  Balancing	  
Sex	  is	  a	  biological	  category	  that	  can	  refer	  to	  chromosomal	  sex,	  genetic	  sex,	  
gonadal	  sex,	  and	  hormonal	  sex.	  Gender	  is	  a	  social	  category	  characterized	  by	  
physiological	  sex,	  gender	  identity,	  social	  identity,	  and	  sexual	  orientation	  
(Seavilleklein	  &	  Sherwin,	  2007).	  The	  distinction	  is	  important	  because	  equating	  sex	  
with	  gender	  may	  disregard	  the	  reality	  of	  intersexuality,	  transsexuality,	  and	  
homosexuality.	  Although	  sex	  selection	  sorts	  embryos	  according	  to	  their	  sex	  
chromosomes	  (XX	  or	  XY),	  parents	  using	  NMSS	  may	  be	  intending	  to	  select	  gender	  
rather	  than	  sex.	  	  At	  the	  individual	  level,	  the	  desire	  to	  select	  for	  a	  particular	  gender	  
may	  be,	  at	  least	  in	  part,	  a	  product	  of	  unconscious,	  internalized	  gender	  stereotypes.	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However,	  couples	  are	  likely	  not	  overtly	  considering	  or	  aware	  of	  these	  issues	  when	  
they	  request	  sex	  selection	  (Seavilleklein	  &	  Sherwin,	  2007).	  	  
At	  the	  broader	  societal	  level,	  many	  people	  argue	  that	  NMSS	  inherently,	  if	  
unintentionally,	  perpetuates	  gender	  stereotypes	  and	  propagates	  harmful	  attitudes	  
and	  behaviors,	  especially	  when	  those	  biases	  are	  subtle	  (Whittaker,	  2011).	  In	  the	  US,	  
thus	  far,	  there	  doesn’t	  seem	  to	  be	  any	  indication	  that	  one	  sex	  is	  significantly	  
preferred	  over	  another;	  if	  anything,	  there	  is	  a	  non-­‐significant	  trend	  toward	  
preference	  for	  females	  (Van	  Balen,	  2006).	  Fertility	  clinics	  in	  the	  US	  and	  UK	  report	  
that	  80-­‐90%	  of	  people	  using	  sex	  selection	  technology	  gave	  “family	  balancing”	  as	  
their	  main	  motivation	  (Levy,	  2007).	  In	  one	  study,	  the	  analysis	  of	  a	  large	  series	  of	  
PGD	  procedures	  for	  gender	  selection	  from	  a	  wide	  geographical	  area	  in	  the	  USA	  
showed	  that	  in	  cases	  where	  only	  normal	  embryos	  of	  the	  non-­‐	  desired	  gender	  are	  
available,	  45.5%	  of	  the	  couples	  elect	  to	  cancel	  the	  transfer,	  while	  54.5%	  of	  them	  are	  
open	  to	  have	  embryos	  transferred	  of	  the	  non-­‐desired	  gender,	  this	  fact	  being	  strongly	  
linked	  to	  cultural	  and	  ethnic	  background	  of	  the	  parents.	  	  
	   	  
Sex	  Ratio	  Skew	  	  
While	  clinical	  use	  of	  techniques	  for	  sex	  selection	  is	  gaining	  recognition	  in	  a	  
powerful	  global	  market,	  more	  attention	  is	  drawn	  to	  the	  significant	  sex	  ratio	  skew	  
evident	  in	  several	  Asian	  countries	  including	  India,	  China,	  Pakistan,	  and	  Bangladesh.	  	  
As	  of	  2005,	  India	  had	  a	  sex	  ratio	  of	  107.5	  males	  to	  100	  females;	  in	  China,	  the	  figure	  
was	  106.8;	  in	  Pakistan,	  106.0;	  and	  104.9	  in	  Bangladesh.	  Of	  note,	  these	  four	  countries	  
accounted	  for	  43%	  of	  the	  world’s	  total	  population	  in	  2005.	  This	  is	  important	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because	  according	  to	  the	  United	  Nations	  Population	  Fund,	  ‘‘if	  the	  continent’s	  overall	  
sex	  ratio	  was	  the	  same	  as	  elsewhere	  in	  the	  world,	  in	  2005	  Asia’s	  population	  would	  
have	  included	  almost	  163	  million	  more	  women	  and	  girls”	  (Macklin,	  2010).	  ).	  In	  fact,	  
a	  “global	  marketplace”	  for	  non-­‐medical	  sex	  selection	  has	  arisen,	  catering	  to	  couples	  
who	  will	  travel	  to	  another	  country	  for	  a	  procedure	  because	  their	  own	  country	  
forbids	  it.	  Some	  researchers	  are	  predicting	  that	  the	  sex	  imbalance	  will	  be	  self-­‐
correcting	  because	  the	  rarity	  of	  females	  will	  eventually	  increase	  their	  value	  and	  
motivate	  families	  to	  raise	  their	  daughters	  (Levy,	  2007).	  	  Others	  say	  that	  there	  is	  
evidence	  to	  suggest	  that	  the	  sex	  ratio	  is	  becoming	  increasingly	  skewed	  (Levy,	  2007).	  	  	  
One	  cross-­‐sectional	  web-­‐based	  survey	  assessed	  preferences	  for	  sex	  of	  
children	  and	  demand	  for	  NMSS	  of	  a	  sample	  of	  the	  US	  general	  population	  (N=1197)	  
in	  order	  to	  test	  the	  likelihood	  of	  a	  sex	  ratio	  skew	  caused	  by	  NMSS.	  The	  survey	  found	  
that	  only	  8%	  would	  use	  preconception	  sex	  selection	  technology	  while	  74%	  would	  
not.	  Even	  if	  the	  process	  were	  as	  simple	  as	  taking	  a	  pill,	  blue	  for	  a	  boy	  and	  pink	  for	  a	  
girl,	  18%	  would	  be	  willing	  to	  use	  this	  pill,	  but	  the	  majority,	  59%,	  were	  still	  opposed;	  
nearly	  one-­‐fourth	  of	  participants	  were	  undecided.	  When	  asked	  about	  sex	  
preferences,	  39%	  wanted	  their	  first	  child	  to	  be	  a	  son,	  19%	  a	  daughter,	  and	  42%	  had	  
no	  preference.	  The	  authors	  concluded	  that	  NMSS	  would	  not	  change	  the	  gender	  
balance	  in	  the	  US	  for	  two	  reasons:	  not	  enough	  access	  and	  not	  enough	  interest	  in	  one	  
sex.	  (Dahl	  et	  al,	  2006).	  	  
In	  another	  study,	  of	  92	  couples	  undergoing	  IVF	  for	  family	  balancing	  between	  
2004	  and	  2006,	  36	  cycles	  were	  for	  females	  and	  56	  for	  males.	  Overall,	  this	  seems	  to	  
indicate	  a	  lack	  of	  preference	  for	  one	  sex	  over	  the	  other.	  However,	  the	  patterns	  in	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gender	  selection	  were	  significantly	  different	  by	  ethnicity.	  Chinese,	  Arab/Muslim,	  
and	  Asian-­‐Indian	  couples	  primarily	  selected	  for	  males,	  while	  other	  ethnicities	  
(Caucasian	  and	  Hispanic)	  preferentially	  selected	  for	  females.	  This	  supports	  the	  idea	  
that	  there	  are	  still	  cultural	  biases	  against	  females	  in	  certain	  populations	  and	  that	  
this	  is	  an	  important	  ethical	  consideration	  in	  the	  regulation	  of	  NMSS.	  (Gleicher	  and	  
Barad,	  2007).	  
Given	  that	  PGD	  is	  prohibitively	  expensive	  and	  physically	  invasive	  it	  is	  a	  self-­‐
limiting	  procedure	  for	  the	  time	  being.	  This,	  in	  addition	  to	  the	  previously	  mentioned	  
evidence,	  have	  led	  many	  researchers	  to	  predict	  that	  NMSS	  is	  not	  likely	  to	  have	  a	  
significant	  effect	  on	  the	  US’s	  sex	  ratio	  (Levy,	  2007).	  Even	  so,	  there	  is	  considerable	  
literature	  devoted	  to	  disputes	  between	  pro-­‐NMSS	  and	  anti-­‐NMSS	  concerning	  the	  
ethical	  ramifications	  of	  sex	  selection	  as	  it	  relates	  to	  individual	  and	  societal	  
conceptions	  of	  gender.	  	  
	  
NMSS:	  Additional	  Implications	  
Gender	  selection	  is	  controversial	  because	  of	  possible	  implications	  on	  
individual	  and	  societal	  levels	  (Seavilleklein	  &	  Sherwin,	  2007).	  At	  the	  broader	  
societal	  level,	  many	  people	  argue	  that	  perpetuating	  gender	  stereotypes	  propagates	  
harmful	  attitudes	  and	  behaviors,	  especially	  when	  those	  biases	  are	  subtle	  (Whittaker,	  
2011).	  The	  belief	  that	  one	  gender	  is	  superior	  is	  not	  the	  most	  common	  gender-­‐
related	  bias	  held	  in	  the	  developed	  world;	  people	  are	  more	  inclined	  to	  think	  of	  the	  
genders	  as	  having	  equal	  value,	  but	  as	  being	  suited	  to	  different	  roles	  or	  occupations	  
(Levy	  2007).	  In	  the	  US,	  thus	  far,	  there	  doesn’t	  seem	  to	  be	  any	  indication	  that	  one	  sex	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is	  significantly	  preferred	  over	  another;	  once	  again,	  there	  is	  a	  non-­‐significant	  trend	  
toward	  preference	  for	  females	  (Van	  Balen,	  2006).	  	  	  
Possible	  negative	  consequences	  of	  family	  balancing	  suggested	  in	  the	  
bioethics	  literature	  include	  reinforced/increased	  sexism;	  perceptions	  of	  children	  as	  
commodities;	  psychological	  harm	  to	  non-­‐selected	  children;	  unrealistic	  pressure	  on	  
sex-­‐selected	  children	  to	  conform	  to	  gender	  roles;	  undue	  physical	  burden	  on	  women;	  
unjust	  allocation	  of	  medical	  resources;	  destruction	  of	  healthy	  embryos;	  
exacerbation	  of	  socioeconomic	  differences;	  and	  conflict	  with	  the	  parental	  ideal	  of	  
unconditional	  love	  for	  children	  (Jones,	  2001;	  Sharp	  et	  al.,	  2010).	  	  Those	  in	  favor	  of	  
NMSS	  and	  against	  restrictive	  regulation	  believe	  in	  the	  supreme	  importance	  of	  
reproductive	  autonomy.	  Many	  physicians	  who	  offer	  NMSS	  believe	  it	  benefits	  the	  
families	  because	  it	  gives	  them	  a	  child	  that	  enhances	  the	  experiences	  of	  his/her	  
siblings	  or	  allows	  for	  better	  family	  planning.	  Physicians	  also	  value	  NMSS	  because	  
there	  is	  significant	  cultural	  pressure	  on	  some	  women	  to	  have	  a	  child	  of	  a	  specific	  




This	  study	  aims	  to	  understand	  the	  perspectives	  of	  physicians	  on	  the	  ethics	  of	  
NMSS	  as	  well	  as	  their	  experiences,	  and,	  as	  such,	  this	  study's	  conceptual	  framework	  
borrows	  heavily	  from	  bioethics'	  "moral	  experience	  framework."	  Moral	  experience,	  
as	  defined	  by	  Hunt	  and	  Carnevale	  (2011),	  encompasses	  a	  person's	  sense	  that	  
his/her	  important	  values	  are	  being	  realized	  or	  thwarted	  in	  everyday	  life;	  this	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includes	  the	  person's	  interpretation	  of	  lived	  encounter(s)	  as	  falling	  within	  the	  
spectrum	  of	  right-­‐wrong,	  good-­‐bad,	  or	  just-­‐unjust	  (Hunt	  &	  Carnevale,	  2011).	  A	  
situation	  characterized	  by	  ambivalence	  may	  also	  be	  a	  moral	  experience	  if	  the	  
experience	  is	  relevant	  to	  a	  person's	  values.	  Furthermore,	  a	  "diffuse	  feeling	  of	  
unfairness"	  is	  as	  much	  a	  moral	  experience	  as	  an	  "acutely	  felt	  sense	  of	  manifest	  
injustice"	  (Hunt	  &	  Carnevale,	  2011).	  	  The	  major	  principles	  of	  bioethics	  may	  inform	  
the	  types	  of	  values	  that	  physicians	  draw	  on,	  including	  values	  related	  to	  autonomy,	  
justice,	  and	  beneficence.	  The	  framework	  has	  been	  used	  previously	  in	  studies	  of	  the	  
moral	  experience	  of	  healthcare	  professionals	  with	  patients,	  the	  pharmaceutical	  
industry,	  and	  hospice	  care	  (Gibson	  et	  al,	  2012;	  Osborn,	  2012;	  Carnevale,	  2013).	  	  
	  
REPRODUCTIVE	  AUTONOMY	  AND	  REPRODUCTIVE	  DECISION-­MAKING	  	  
Proponents	  of	  NMSS,	  ranging	  from	  physicians	  to	  researchers	  to	  ethicists,	  believe	  
that	  reproductive	  autonomy,	  which	  is	  the	  inability	  of	  the	  government	  to	  infringe	  
upon	  the	  right	  of	  individuals	  to	  make	  reproductive	  choices	  for	  themselves,	  would	  be	  
jeopardized	  if	  NMSS	  were	  illegalized	  or	  restricted.	  Opponents	  believe	  that	  
reproductive	  autonomy	  is	  trumped	  by	  human	  rights	  principles,	  relevant	  if	  
detrimental	  effects	  of	  sex	  selection	  are	  recognized	  as	  a	  global	  issue	  (Whittaker,	  
2011).	  The	  significant	  role	  of	  reproductive	  autonomy	  cannot	  be	  overemphasized;	  in	  
a	  comparison	  of	  the	  attitudes	  of	  primary	  care	  providers	  and	  reproductive	  
endocrinologists,	  “patient	  autonomy”	  was	  the	  single	  most	  commonly	  mentioned	  
ethical	  argument	  both	  for	  and	  against	  sex	  selection	  (Puri	  &	  Nachtigall,	  2010).	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In	  light	  of	  the	  possible	  effects	  of	  the	  use	  of	  NMSS,	  it	  is	  important	  to	  understand	  
the	  context	  in	  which	  couples	  and	  providers	  make	  decisions	  about	  reproductive	  
technologies.	  	  Although	  research	  on	  NMSS	  is	  more	  limited	  than	  research	  on	  other	  
prenatal	  testing	  procedures,	  findings	  from	  a	  series	  of	  ethnographic	  interviews	  with	  
couples	  pursing	  NMSS	  via	  PGD	  suggest	  that	  some	  couples	  recognize	  it	  as	  an	  ethically	  
complex	  decision	  and	  experience	  ambivalence	  about	  its	  acceptability	  (Sharp	  et	  al,	  
2010).	  	  Further	  research	  is	  needed	  to	  characterize	  the	  moral	  ambivalence,	  if	  any,	  of	  
the	  NMSS	  referrers	  and	  providers.	  
	  
PHYSICIANS’	  ATTITUDES	  AND	  PROFESSIONAL	  ETHICS	  
The	  decision	  to	  use	  or	  provide	  access	  to	  reproductive	  technologies,	  especially	  
PGD,	  may	  be	  marked	  by	  complex	  moral,	  ethical,	  and	  societal	  issues.	  Some	  
researchers	  believe	  that	  there	  should	  be	  limits	  on	  this	  technology,	  but	  there	  is	  no	  
consensus	  as	  to	  how	  this	  might	  reasonably	  be	  done,	  if	  at	  all	  (McMahon,	  2004).	  In	  its	  
ethics	  consensus	  statement,	  the	  ASRM	  concluded,	  that	  despite	  “serious	  ethical	  
concerns,”	  they	  would	  need	  “more	  clearly	  persuasive	  ethical	  argument[s]”	  or	  
“stronger	  empirical	  evidence”	  for	  harm	  before	  they	  would	  consider	  creating	  policies	  
to	  prohibit	  or	  condemn	  nonmedical	  preconception	  sex	  selection	  (Puri	  &	  Nachtigall,	  
2010).	  With	  ambiguous	  guidelines	  and	  a	  lack	  of	  legislation,	  physicians	  report	  that	  
often	  they	  are	  individually	  making	  ethical,	  even	  legal,	  decisions	  based	  on	  their	  own	  
judgments	  (Caldas	  et	  al,	  2010).	  	  
	   In	  a	  cross-­‐sectional	  survey	  of	  Brazilian	  OBGYNs’	  views	  on	  SS	  via	  PGD,	  Caldas	  
et	  al	  found	  that	  36.4%	  felt	  that	  NMSS	  is	  always	  the	  couple’s	  choice,	  42.6%	  believed	  it	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should	  be	  the	  couple’s	  choice	  only	  in	  certain	  situations,	  and	  17.6%	  did	  not	  believe	  
that	  NMSS	  should	  ever	  be	  the	  couple’s	  choice	  (2010).	  A	  large	  majority	  of	  these	  
physicians	  felt	  positively	  about	  PGD	  use,	  so	  the	  differing	  opinions	  seem	  to	  be	  a	  
function	  of	  considering	  NMSS	  rather	  than	  a	  more	  general	  problem	  with	  the	  selection	  
of	  embryos.	  For	  those	  who	  opposed	  NMSS,	  70%	  chose	  the	  explanation	  that	  “all	  
children	  are	  welcome”	  and	  almost	  20%	  chose	  the	  explanation	  of	  “unnatural.”	  Other	  
reasons	  for	  opposing	  NMSS	  included	  “not	  wanting	  to	  play	  God,”	  and	  concerns	  about	  
a	  sex-­‐ratio	  imbalance,	  though	  these	  options	  were	  chosen	  by	  fewer	  participants	  (9%	  
and	  3%	  respectively).	  	  Of	  note,	  male	  OBGYNs	  in	  this	  study	  were	  twice	  as	  likely	  as	  
females	  to	  be	  in	  favor	  of	  SS	  (Caldas	  et	  al,	  2010).	  	  
In	  a	  recent	  survey	  of	  220	  US	  internists,	  about	  half	  (49.4%)	  would	  not	  
recommend	  PGD	  for	  non-­‐medical	  sex	  selection,	  45.4%	  were	  unsure,	  and	  only	  5.2%	  
would	  recommend	  PGD	  for	  NMSS.	  Of	  the	  220,	  only	  4.9%	  had	  actually	  suggested	  PGD	  
for	  any	  indication	  to	  patients	  and	  only	  7.1%	  felt	  capable	  of	  answering	  questions	  
from	  patients	  (Klitzman	  et	  al,	  2013).	  These	  findings	  suggest	  the	  presence	  of	  a	  great	  
deal	  of	  uncertainty	  and	  ambivalence	  about	  the	  use	  of	  PGD,	  both	  in	  the	  context	  of	  
NMSS	  and	  for	  medical	  purposes	  among	  internists.	  	  The	  researchers	  use	  their	  
findings	  to	  emphasize	  the	  importance	  of	  future	  research	  in	  understanding	  how	  
physicians	  make	  decisions	  about	  PGD	  referrals	  as	  well	  as	  what	  variables	  related	  to	  
characteristics	  of	  providers	  influence	  referrals	  (Klitzman	  et	  al,	  2013).	  	  	  	  
Puri	  and	  Nachtigall’s	  interview-­‐based	  study	  comparing	  primary	  care	  
physicians’	  (PCPS)	  and	  physician	  sex-­‐selection	  technology	  providers’	  (SSTPs)	  
attitudes	  toward	  sex	  selection	  found	  SSTPs	  were	  in	  favor	  of	  sex	  selection	  as	  an	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expression	  of	  reproductive	  rights,	  as	  a	  sign	  of	  female	  empowerment,	  as	  a	  method	  of	  
family	  planning	  and	  preventing	  unwanted	  pregnancies,	  and	  as	  a	  way	  of	  minimizing	  
abuse	  of	  wives	  or	  neglect	  of	  children.	  PCPs	  were	  more	  cautious	  about	  NMSS,	  
questioning	  whether	  women	  were	  actually	  exercising	  autonomy	  when	  under	  
significant	  family	  pressure;	  they	  did	  not	  see	  NMSS	  as	  a	  solution	  to	  domestic	  
violence.	  They	  were	  concerned	  that	  SS	  technologies	  were	  invasive	  interventions	  
without	  therapeutic	  indications,	  that	  they	  could	  contribute	  to	  gender	  stereotypes,	  
and	  that	  there	  could	  be	  detrimental	  psychological	  consequences	  for	  non-­‐selected	  
children	  (Puri	  &	  Nachtigall,	  2010).	  Still	  lacking	  in	  the	  literature	  are	  studies	  that	  elicit	  
the	  opinions	  of	  the	  clinicians	  who	  are	  actually	  most	  likely	  to	  engage	  in	  assisted	  
reproductive	  technology	  (ART)	  and	  NMSS	  practices	  (Caldas	  et	  al,	  2010).	  
One	  study	  of	  fertility	  clinic	  directors	  gave	  them	  ethically	  complex	  case	  
scenarios	  to	  evaluate.	  For	  each	  scenario,	  the	  director	  had	  to	  decide	  whether	  (s)he	  
would	  offer	  treatment.	  One	  of	  the	  scenarios	  was	  based	  on	  non-­‐medical	  sex	  selection.	  
Those	  who	  did	  not	  support	  treatment	  cited	  their	  philosophy	  of	  medicine,	  including	  
concerns	  about	  misuse	  of	  medical	  technology	  or	  use	  for	  non-­‐disease	  conditions,	  
both	  concerns	  related	  to	  the	  principle	  of	  justice.	  Some	  described	  the	  technology	  as	  
unethical	  or	  a	  “slippery	  slope”	  to	  greater	  misuse.	  They	  were	  also	  concerned	  about	  
discrimination,	  particularly	  sexism	  and	  the	  implications	  of	  sex	  selection	  on	  sex	  
ratios	  and	  the	  value	  of	  women	  in	  society.	  Yet,	  many	  participants	  who	  did	  not	  
support	  the	  treatment	  permitted	  patients	  to	  use	  the	  technology	  out	  of	  respect	  for	  
patient	  autonomy,	  suggesting	  that	  this	  value	  plays	  a	  powerful	  role	  in	  physicians’	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decision-­‐making	  (Stern	  et	  al,	  2003).	  Clinic	  directors	  may	  have	  resolved	  their	  
discrepant	  views	  by	  allowing	  the	  value	  of	  autonomy	  to	  trump	  their	  other	  values.	  
	  
THE	  ROLE	  OF	  THE	  PHYSICIAN	  IN	  DECISION-­MAKING	  
Physicians	  are	  ideally	  positioned	  to	  be	  the	  gatekeepers	  for	  reproductive	  
technology	  and	  currently	  function	  in	  that	  capacity	  in	  many	  regards.	  In	  2004,	  health	  
care	  providers	  were	  already	  reporting	  that	  couples	  often	  asked	  whether	  sex	  
selection	  was	  possible	  (Sauer,	  2004).	  Currently,	  physicians	  make	  recommendations	  
and	  referrals	  with	  minimal	  and	  often	  conflicting	  guidance	  from	  medical	  societies.	  It	  
is	  clear	  from	  the	  relevant	  research	  that	  physicians	  differ	  in	  their	  attitudes	  by	  field	  
and	  possibly	  by	  gender	  ,	  but	  little	  is	  known	  about	  the	  underlying	  principles	  or	  
values	  used	  by	  physicians	  when	  making	  decisions	  about	  ethically	  ambiguous	  issues	  
(Caldas	  et	  al,	  2010;	  Puri	  &	  Nachtigall,	  2010).	  The	  views	  and	  practices	  of	  IVF	  
providers	  and	  obstetricians	  could	  be	  informative	  for	  creating	  useful	  practice	  
guidelines	  and	  elucidating	  ethical	  concerns	  (Klitzman	  et	  al,	  2008).	  In	  Puri	  and	  
Nachtigall’s	  study,	  providers	  reported	  that,	  though	  infrequent,	  the	  accompanying	  
emotional	  impact	  ensured	  that	  sex	  selection	  cases	  were	  memorable	  (2010).	  	  
	  
PGD,	  NMSS,	  &	  THE	  “SLIPPERY	  SLOPE”	  
Scientists	  and	  non-­‐scientists	  alike	  have	  voiced	  concerns	  over	  the	  possible	  
“slippery	  slope”	  from	  NMSS	  to	  the	  ethically	  charged	  idea	  of	  what	  some	  have	  called	  
“designer	  babies”	  (Dahl,	  2003;	  Jones	  &	  McMahon,	  2003;	  Klitzman	  et	  al,	  2008).	  The	  
“slippery	  slope”	  refers	  to	  the	  first	  non-­‐medical	  use	  of	  PGD,	  NMSS,	  leading	  to	  future	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non-­‐medical	  uses,	  specifically	  non-­‐medical	  trait	  selection.	  Unlike	  the	  eugenics	  
movements	  of	  the	  twentieth	  century,	  during	  which	  there	  was	  a	  broader	  social	  
agenda	  of	  the	  state	  to	  determine	  who	  was	  genetically	  fit	  to	  reproduce,	  PGD	  decision-­‐
making	  today	  seems	  to	  occur	  on	  an	  individual	  level	  (Hershberger	  &	  Pierce,	  2010).	  
The	  German	  Institute	  for	  Demoscopy	  surveyed	  1044	  men	  and	  women	  (16	  and	  
older)	  from	  the	  general	  population	  about	  attitudes	  toward	  non-­‐medical	  trait	  
selection.	  80%	  disapproved	  of	  “designer	  babies.”	  The	  20%	  who	  did	  not	  disapprove	  
were	  asked	  for	  which	  characteristics	  they	  would	  select:	  45%	  would	  select	  for	  
intelligence,	  28%	  for	  sex	  (6%	  of	  the	  entire	  sample),	  17%	  for	  physical	  prowess,	  13%	  
for	  height,	  12%	  for	  artistic	  talent,	  4%	  for	  hair	  color,	  and	  4%	  for	  eye	  color	  (Dahl,	  
2003).	  	  
In	  2013,	  a	  nationally	  representative	  sample	  of	  U.S.	  residents	  (aged	  18-­‐75)	  
(N=1066)	  were	  surveyed	  online	  about	  their	  perspectives	  on	  PGD.	  The	  majority	  of	  
respondents	  approve	  of	  its	  use	  for	  identifying	  early-­‐onset	  life-­‐limiting	  conditions.	  
However,	  only	  21%	  support	  its	  use	  for	  sex	  selection.	  Asked	  about	  other	  non-­‐medical	  
traits,	  19%	  support	  the	  use	  of	  PGD	  for	  personality	  traits,	  15%	  for	  physical	  traits,	  and	  
13%	  for	  sexual	  orientation.	  Compared	  to	  women,	  men	  were	  two	  to	  three-­‐fold	  more	  
likely	  to	  endorse	  PGD	  for	  sex	  selection	  or	  non-­‐medical	  traits.	  Also	  significant	  is	  the	  
finding	  that	  Asians	  were	  four	  times	  more	  supportive	  of	  PGD	  for	  sex	  selection	  
compared	  to	  Caucasians.	  Those	  with	  a	  graduate	  degree	  (college	  and	  above)	  were	  
more	  opposed	  to	  sex	  selection	  and	  non-­‐medical	  trait	  selection	  compared	  to	  those	  
without	  a	  college	  degree.	  In	  general,	  respondents	  were	  more	  supportive	  of	  PGD	  for	  
genetic	  diseases	  if	  they	  were	  aware	  of	  PGD	  prior	  to	  the	  survey	  (Winkelman	  et	  al,	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2014).	  As	  previous	  literature	  shows,	  there	  is	  variation	  in	  physicians’	  attitudes	  
towards	  NMSS;	  it	  may	  be	  that	  some	  of	  these	  attitudes	  are	  also	  relevant	  in	  
considering	  policies	  related	  to	  other	  non-­‐medical	  traits	  (McMahon,	  2004).	  
	  
SIGNIFICANCE	  
There	  is	  a	  dearth	  of	  literature	  dedicated	  to	  eliciting	  the	  attitudes	  and	  
perspectives	  of	  healthcare	  providers	  around	  the	  ethics	  and	  use	  of	  PGD	  for	  NMSS.	  
The	  significance	  of	  this	  research	  is	  multi-­‐tiered	  with	  potential	  significance	  at	  the	  
level	  of	  the	  individual	  as	  well	  as	  society,	  both	  locally	  and	  globally.	  Research	  in	  this	  
area	  may	  impact	  practice	  guidelines	  as	  well	  as	  providing	  information	  about	  the	  
moral	  experiences	  of	  physicians	  in	  this	  area.	  Puri	  and	  Nachtigall	  call	  for	  research	  on	  
the	  perspectives	  of	  physicians	  involved	  in	  or	  aware	  of	  sex	  selection	  in	  order	  to	  
ground	  ethical	  debates	  within	  the	  experiences	  of	  clinicians	  in	  different	  specialties	  
(Puri	  &	  Nachtigall,	  2010).	  Furthermore,	  understanding	  how	  physicians	  decide	  on	  
hypothetically	  “appropriate”	  non-­‐medical	  traits	  may	  suggest	  that	  the	  values	  
influencing	  where	  they	  “draw	  the	  line”	  overlap	  with	  or	  diverge	  from	  those	  that	  
influence	  attitudes	  toward	  NMSS.	  Unlike	  previous	  studies,	  this	  study	  attempts	  to	  
elicit,	  rather	  than	  provide,	  the	  reasons	  for	  physicians’	  attitudes	  toward	  NMSS	  as	  well	  
as	  seeking	  a	  more	  nuanced	  understanding	  of	  those	  attitudes.	  Future	  quantitative	  
work	  in	  this	  topic	  would	  be	  informed	  by	  a	  deeper	  knowledge	  about	  physicians’	  
attitudes	  and	  preferences	  and	  would	  inform	  researchers	  about	  the	  best	  questions	  to	  
ask	  in	  follow-­‐up.	  Findings	  may	  influence	  patient-­‐provider	  communication	  around	  
decision-­‐making	  and,	  eventually,	  communication	  norms	  may	  influence	  policy.	  	  This	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research	  can	  illuminate	  larger	  societal	  implications	  if	  use	  of	  NMSS	  technology	  
becomes	  more	  widespread,	  especially	  the	  extent	  to	  which	  people	  are	  grappling	  with	  
the	  effects	  of	  individual	  decisions	  on	  broader	  issues.	  	  
	  
OBJECTIVE	  AND	  SPECIFIC	  AIMS	  
The	  American	  College	  of	  Obstetrics	  and	  Gynecology	  (ACOG)	  and	  the	  
American	  Society	  for	  Reproductive	  Medicine	  (ASRM),	  the	  professional	  societies	  
most	  relevant	  to	  physician	  populations	  studied	  here,	  disagree	  in	  their	  
recommendations	  around	  the	  use	  of	  PGD	  for	  NMSS.	  	  However,	  both	  appreciate	  that	  
there	  are	  complex	  ethical	  concerns	  inherent	  to	  the	  practice,	  the	  recognition	  of	  which	  
forms	  the	  basis	  of	  their	  recommendations.	  The	  ASRM,	  in	  their	  professional	  
statement	  on	  NMSS,	  calls	  for	  more	  research	  into	  the	  consequences	  of	  this	  practice.	  
Neither	  society	  makes	  clear	  the	  role	  of	  the	  HCPs,	  who	  are	  positioned	  to	  be	  
gatekeepers	  of	  the	  technology,	  nor	  is	  there	  a	  consensus	  as	  to	  what	  role	  HCPs	  prefer	  
to	  play	  in	  this	  process.	  Recognizing	  that	  NMSS	  is	  the	  first	  non-­‐medical	  use	  of	  PGD,	  it	  
is	  essential	  to	  elicit	  the	  attitudes	  and	  concerns,	  if	  any,	  of	  HCPs,	  in	  order	  to	  ground	  
ethical	  debates	  about	  sex	  selection	  as	  well	  as	  allowing	  professional	  medical	  
organizations	  to	  clarify	  their	  guidelines.	  
This	  study	  seeks	  to	  describe	  the	  experiences	  of	  healthcare	  providers	  around	  
pre-­‐implantation	  genetic	  diagnosis	  (PGD)	  for	  non-­‐medical	  sex	  selection	  (NMSS),	  
with	  a	  particular	  focus	  on	  potential	  ethical	  concerns,	  their	  role	  in	  the	  decision-­‐
making	  process,	  and	  their	  views	  on	  future	  appropriate	  and	  inappropriate	  non-­‐
medical	  uses	  of	  PGD.	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Specific	  Aim	  1:	  To	  describe	  the	  experiences	  healthcare	  providers	  (HCPs)	  have	  had	  
around	  non-­‐medical	  sex	  selection	  (NMSS),	  as	  well	  as	  their	  attitudes	  toward	  and	  
perceptions	  of	  previous	  experiences	  and	  hypothetical	  NMSS	  scenarios.	  
Specific	  Aim	  2:	  To	  describe	  perceptions	  HCPs	  have,	  if	  any,	  about	  the	  implications	  of	  
NMSS.	  
Sub-­‐aim1:	  To	  elicit	  perceptions	  of	  individual-­‐level	  implications.	  
Sub-­‐aim2:	  To	  elicit	  perceptions	  of	  societal/global-­‐level	  implications.	  
Specific	  Aim	  3:	  To	  explore	  HCPs’	  perceptions	  about	  NMSS	  decision-­‐making	  and	  
their	  current	  and	  preferred	  roles	  in	  the	  process	  of	  decision-­‐making.	  
Specific	  Aim	  4:	  To	  elicit	  other	  traits	  considered	  by	  HCPs	  to	  be	  appropriate	  (or	  not)	  
for	  selection	  through	  PGD	  and	  explore	  how	  they	  make	  those	  distinctions.	  	  	  
	  
METHODS	  
STUDY	  DESIGN	  	  
This	  is	  a	  qualitative,	  cross-­‐sectional	  study	  in	  which	  one-­‐time	  semi-­‐structured	  
interviews	  were	  conducted	  with	  a	  purposive	  sample	  of	  OB/GYNS	  (n=8)	  and	  
reproductive	  endocrinologists	  (REs)	  (n=6).	  	  Interviews	  were	  coded	  in	  an	  iterative	  
process	  using	  a	  codebook	  that	  evolved	  as	  themes	  emerged	  (Appendix	  G).	  
Interviews	  took	  place	  by	  telephone	  to	  facilitate	  recruitment	  beyond	  a	  limited	  
geographical	  area.	  This	  qualitative	  study	  is	  one	  of	  the	  first	  in	  which	  attitudes	  and	  
experiences	  of	  these	  particular	  medical	  specialties	  have	  been	  elicited.	  The	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qualitative	  design	  allowed	  flexibility	  during	  data	  collection	  as	  well	  as	  the	  potential	  
to	  capture	  unanticipated	  themes	  through	  in-­‐depth	  analysis.	  
	  
STUDY	  SAMPLE	  AND	  RECRUITMENT	  PROCEDURE	  
Participating	  physicians	  were	  recruited	  via	  cover	  letters	  (Appendix	  A)	  
explaining	  the	  study	  and	  received	  an	  opt-­‐out	  letter	  in	  a	  pre-­‐paid	  envelope	  
(Appendix	  F).	  Addresses	  were	  obtained	  from	  the	  websites	  of	  the	  American	  College	  
of	  Obstetrics	  and	  Gynecology	  (ACOG)	  and	  the	  American	  Society	  for	  Reproductive	  
Medicine	  (ASRM).	  Two	  rounds	  of	  letters	  (n=120	  and	  n=40)	  were	  sent	  out	  to	  
physicians	  chosen	  at	  random	  from	  across	  the	  United	  States.	  The	  interviewer	  (NH)	  
followed-­‐up	  by	  phone	  two	  weeks	  after	  each	  mailing.	  Eligibility	  was	  confirmed	  and	  
interview	  times	  were	  scheduled	  during	  the	  phone	  call.	  Consent	  forms	  (Appendix	  B)	  
were	  sent	  (via	  fax	  or	  email)	  to	  participants	  before	  the	  day	  of	  the	  interview	  so	  that	  
verbal	  consent	  could	  be	  obtained	  on	  the	  phone	  just	  prior	  to	  the	  interview.	  	  
Because	  response	  rate	  was	  poor	  after	  several	  months	  (n=6;	  <5%),	  a	  
secondary	  recruitment	  took	  place	  in	  which	  cover	  letters	  were	  emailed	  to	  the	  
directors	  of	  Reproductive	  Endocrinology	  and	  Infertility	  Fellowship	  programs	  
contained	  in	  the	  ASRM	  and	  Society	  for	  Reproductive	  Endocrinology	  and	  Infertility,	  
Inc(?)	  Directory	  of	  Fellowship	  Programs.	  Snowball	  sampling	  was	  also	  used	  to	  reach	  
a	  greater	  number	  of	  providers.	  Participants	  were	  eligible	  if	  they	  were	  English-­‐
speaking	  physicians	  who	  self-­‐reported	  that	  they	  were	  currently	  practicing	  medicine	  
within	  the	  United	  States	  as	  an	  OB/GYN	  or	  RE,	  or	  were	  practicing	  as	  a	  
resident/fellow	  specializing	  in	  OB/GYN	  or	  reproductive	  endocrinology.	  	  Interviews	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were	  scheduled	  by	  email	  and	  consent	  forms	  were	  emailed	  to	  residents	  before	  their	  
interview.	  	  
	   Prior	  to	  each	  phone	  interview,	  verbal	  consent,	  including	  permission	  to	  record	  
the	  interview,	  was	  obtained.	  Some	  demographic	  information	  was	  collected	  through	  
a	  brief	  questionnaire	  (Appendix	  E)	  given	  before	  the	  interview	  including	  the	  
physician’s	  age,	  sex,	  medical	  specialty,	  type	  of	  workplace,	  characteristics	  of	  their	  
patient	  population,	  broad	  geographic	  location,	  number	  of	  years	  in	  practice,	  and	  
whether	  or	  not	  the	  physician	  was	  a	  parent.	  Furthermore,	  the	  physician	  was	  asked	  
about	  the	  strength	  of	  his/her	  feelings	  toward	  NMSS,	  and	  whether	  he/she	  had	  been	  
actively	  involved	  in	  the	  NMSS	  debate	  or	  tried	  to	  change	  policy	  (Tables	  1	  &	  2).	  
Participants	  were	  not	  compensated	  for	  their	  time.	  	  
	   	  
STUDY	  INSTRUMENT	  AND	  INTERVIEW	  PROCEDURE	  
	   The	  lead	  investigator	  (NH)	  conducted	  all	  of	  the	  interviews,	  which	  lasted	  
approximately	  30	  minutes	  each.	  Interviews	  were	  semi-­‐structured	  and	  guided	  by	  
open-­‐ended	  questions	  and	  follow-­‐up	  probes	  designed	  to	  allow	  the	  interviewer	  to	  
clarify	  statements	  or	  to	  invite	  elaboration	  (Appendix	  C).	  The	  interviews	  were	  
flexible	  and	  participants	  were	  permitted	  to	  elaborate	  on	  any	  topics	  in	  the	  sequence	  
they	  wished.	  The	  interviewer	  allowed	  the	  participants	  to	  lead	  the	  discussion	  so	  that	  
topics	  of	  particular	  salience	  to	  the	  participant	  were	  explored,	  however	  the	  
interviewer	  redirected	  the	  interview	  to	  ensure	  key	  topics	  were	  covered.	  The	  content	  
or	  phrasing	  of	  questions	  was	  clarified	  based	  on	  areas	  of	  confusion.	  Certain	  questions	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received	  more	  or	  less	  focus	  in	  each	  interview	  depending	  on	  their	  relevance	  to	  the	  
specialty	  of	  the	  participant.	  	  
During	  the	  interviews,	  participants	  were	  asked	  to	  share	  a	  narrative	  of	  their	  
clinical	  experiences	  with	  NMSS	  as	  well	  as	  their	  personal	  feelings	  and	  actions	  in	  these	  
situations.	  They	  were	  also	  asked	  how	  they	  address	  NMSS	  requests;	  what	  ethical	  
issues	  they	  believe	  are	  raised	  by	  NMSS,	  if	  any;	  and	  their	  attitudes	  toward	  decision-­‐
making	  around	  NMSS;	  and	  regulation	  of	  the	  use	  of	  NMSS.	  Many	  of	  these	  themes	  
parallel	  themes	  from	  Puri	  &	  Nachtigall’s	  study	  (2010)	  because	  they	  are	  proposed	  to	  
be	  highly	  relevant	  and	  important	  themes	  for	  PCPs	  (including	  OBGYNs)	  and	  sex	  
selection	  technology	  providers	  (SSTPs)	  (including	  reproductive	  endocrinologists).	  
Interviews	  were	  audio-­‐recorded	  and	  transcribed	  by	  professional	  transcription	  
services.	  All	  interviews	  were	  de-­‐identified	  through	  the	  replacement	  of	  personal	  
identifiers	  with	  interview	  identification	  numbers	  and	  demographic	  data	  is	  only	  
reported	  in	  aggregate.	  See	  Appendix	  D	  for	  procedure	  flow	  chart.	  
	  
ANALYSIS	  
A	  qualitative	  analysis	  was	  appropriate	  for	  this	  study	  as	  evidenced	  by	  
previous	  successes	  in	  the	  investigation	  of	  other	  ethical	  controversies	  in	  
reproductive	  medicine	  (e.g.	  prenatal	  diagnosis,	  use	  of	  IVF	  technology)	  (Puri	  &	  
Nachtigall,	  2010).	  A	  qualitative	  study	  is	  preferable	  when	  there	  is	  little	  known	  about	  
the	  experiences	  and	  attitudes	  of	  a	  stakeholder	  group,	  especially	  around	  an	  ethically	  
complex	  issue.	  The	  experiences	  and	  attitudes	  of	  physicians	  toward	  NMSS	  via	  PGD	  
are	  poorly	  understood;	  the	  goal	  of	  thematic	  analysis	  was	  to	  gain	  an	  in-­‐depth	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understanding	  of	  the	  context	  surrounding	  this	  phenomenon,	  particularly	  as	  it	  
concerns	  ethics.	  Hunt	  and	  Carnevale	  believe	  that	  their	  moral	  experience	  framework	  
is	  compatible	  with	  qualitative,	  constructivist	  research	  (2011).	  Constructivism	  
defines	  knowledge	  as	  socially	  constructed,	  signifying	  that	  the	  researcher	  and	  
participants	  co-­‐create	  the	  study's	  results	  and	  that	  no	  a	  priori	  theory	  can	  capture	  the	  
phenomenon	  of	  interest.	  Hunt	  and	  Carnevale	  acknowledge	  that	  a	  researcher	  
studying	  the	  moral	  experiences	  of	  a	  group	  should	  realize	  that	  they	  cannot	  capture	  
the	  complete	  experience,	  but	  can	  attempt	  a	  Gestalt	  based	  on	  fragments	  and	  
cautiously	  evaluate	  the	  normative	  implications	  of	  the	  work	  (2011).	  	  
Analysis	  was	  driven	  by	  the	  codebook,	  which	  itself	  was	  modeled	  on	  the	  
interview	  questions	  and	  themes	  relevant	  to	  the	  ethics-­‐related	  conceptual	  
framework.	  The	  initial	  codebook	  was	  also	  based	  on	  themes	  and	  constructs	  in	  
relevant	  previous	  literature.	  Transcripts	  were	  coded	  in	  an	  iterative	  process	  
throughout	  data	  collection	  and	  refined	  throughout	  the	  analysis	  process	  based	  on	  
emergent	  and/or	  unanticipated	  themes.	  The	  earliest	  transcripts	  were	  coded	  based	  
on	  the	  preliminary	  codebook,	  with	  existing	  codes	  modified	  or	  removed	  as	  more	  
transcripts	  were	  analyzed.	  Transcripts	  were	  assessed	  for	  convergent	  and	  divergent	  
themes.	  The	  main	  content	  areas	  were	  explicitly	  interrogated	  and	  examined	  for	  
common,	  emerging	  trends.	  Codes	  were	  often	  were	  compared	  and	  consolidated	  into	  
major	  categories.	  Illustrative	  quotes	  were	  used	  to	  define	  codes	  and	  describe	  
recurring	  themes.	  Analysis	  of	  sub-­‐groups	  was	  tentatively	  attempted	  with	  the	  
understanding	  that	  thematic	  saturation	  had	  not	  been	  reached	  at	  14	  transcripts	  and	  
therefore	  these	  comparisons	  may	  change	  as	  more	  data	  is	  collected.	  Transcripts	  were	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coded	  using	  NVivo	  software	  to	  assist	  with	  data	  management	  and	  analysis	  of	  
thematic	  content.	  	  
Twenty	  percent	  of	  the	  transcripts	  created	  to	  date	  were	  double	  coded	  by	  
another	  investigator	  using	  the	  same	  codebook	  as	  the	  primary	  coder.	  Thus,	  of	  the	  
first	  14	  transcripts,	  the	  second	  coder	  independently	  reviewed	  and	  coded	  three	  
(approximately	  20%)	  to	  examine	  and	  resolve	  discrepancies	  with	  the	  primary	  coder	  
to	  ensure	  consistent	  application	  of	  the	  codes	  for	  reliability.	  Thus	  far,	  discrepancies	  
have	  been	  readily	  resolved.	  This	  study	  is	  ongoing	  and	  recruitment	  will	  continue	  
with	  the	  goal	  of	  reaching	  theoretical	  saturation	  and	  a	  sample	  of	  30-­‐45	  individuals.	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Table	  1.	  Physician	  Characteristics	  
Physician 
Characteristics   
   
Age   
 N ~% 
30-39 7 50 
40-49 2 14 
50-59 2 14 
60-69 3 21 
   
Gender   
 N ~% 
Male 6 43 
Female 8 57 
   
Specialty   
 N ~% 
OB/GYN 8 57 
RE 6 43 
   
   
Region   
 N ~% 
Northeast 7 50 
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Midwest 1 7 
West 2 14 
South 4 29 
   
Years in Practice   
 N ~% 
<10 7 50 
10 or more 7 50 
   
Parent (Y/N)   
 N ~% 
Yes 12 86 
No 2 14 
   
Strength of Feeling toward NMSS  
 N ~% 
Not Strong 3 21 
Somewhat Strong 6 43 
Strong 1 7 
Very Strong 4 29 
   
Ever Involved in Debate/Policy  
 N ~% 
Yes 1 7 
No 13 93 
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Table	  2.	  Typical	  Patient	  Population	  Demographics	  
	  
Patient Population Demographics  
 N ~% 
Type of Workplace   
Clinic 2 14 
Private Practice 3 21 
Hospital 3 21 
Other 0 0 
Combination 6 43 
   
Majority Caucasian (Y/N) N ~% 
   
Yes 6 43 
No 8 57 
   
% on Public Assistance   
 N ~% 
<50% 9 64 
50% or greater 5 36 
   
% Annual Income > $200K   
 N ~% 
<10% 5 36 
10% or greater 9 64 
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Majority Age Group (Years)   
 N ~% 
<25 2 14 
25-35 3 21 
>35 9 64 
   
	  
FINDINGS	  
Overall,	  our	  participants	  were	  personally	  opposed	  to	  non-­‐medical	  sex	  
selection,	  though	  many	  supported	  patients	  in	  their	  professional	  capacity.	  Almost	  all	  
physicians	  had	  encountered	  requests	  for	  NMSS,	  whether	  it	  was	  for	  family	  balancing,	  
a	  first	  child,	  or	  both.	  Thus,	  many	  were	  able	  to	  discuss	  their	  attitudes	  based	  on	  actual	  
personal	  experience	  with	  requests.	  If	  physicians	  hadn’t	  experienced	  a	  particular	  
scenario,	  they	  were	  asked	  to	  imagine	  their	  response	  and	  feelings	  to	  a	  hypothetical	  
scenario.	  Regardless	  of	  whether	  the	  scenario	  was	  hypothetical	  or	  actual,	  physicians	  
drew	  on	  common	  values	  to	  explain	  their	  attitudes,	  feelings,	  and	  decision-­‐making	  
around	  the	  request..	  	  
	  
VALUES	  	  INFLUENCING	  VIEWS	  ON	  NMSS	  
Medical	  Ethics	  Principles	  
Values	  refer	  to	  one’s	  judgment	  of	  what	  is	  important	  in	  life.	  	  All	  physicians	  
spontaneously	  referred	  to	  their	  values	  when	  discussing	  their	  attitudes	  toward	  
NMSS,	  and	  all	  were	  asked	  specifically	  to	  consider	  the	  values	  and	  beliefs	  they	  held	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that	  influenced	  their	  personal	  and	  professional	  views	  on	  NMSS.	  Most	  of	  the	  values,	  
whether	  mentioned	  without	  prompting,	  or	  raised	  in	  response	  to	  later	  questions,	  
drew	  on	  medical	  ethics	  principles:	  justice,	  autonomy,	  beneficence,	  and	  
nonmaleficence	  (“do	  no	  harm”).	  	  
Autonomy	  seemed	  to	  be	  the	  value	  or	  ethical	  principle	  cited	  most	  often	  by	  all	  
the	  participants.	  Even	  though	  10	  out	  of	  14	  physicians	  were	  clearly	  not	  in	  favor	  of	  
NMSS,	  more	  than	  50%	  of	  them	  would	  support	  a	  patient	  in	  obtaining	  NMSS	  (though	  
the	  number	  varied	  between	  the	  “family	  balancing”	  and	  “first	  child”	  contexts)	  
because	  of	  their	  respect	  for	  patient	  autonomy	  and	  reproductive	  decision-­‐making.	  
When	  physicians’	  personal	  views	  and	  professional	  actions	  around	  NMSS	  were	  at	  
odds,	  they	  were	  likely	  to	  explain	  the	  inconsistency	  by	  promoting	  the	  importance	  of	  
patient	  autonomy.	  Paradoxically,	  the	  belief	  in	  patient	  autonomy	  was	  also	  the	  most	  
likely	  value	  to	  cause	  the	  physician	  to	  feel	  conflicted.	  
	  
“And	  so,	  I	  do	  feel	  really	  strongly	  that	  people	  should	  be	  able	  to	  choose	  parenthood	  or	  
lack	  of	  parenthood.	  And,	  so,	  I	  do	  really	  feel	  compelled	  by	  personal	  choices,	  about	  
families,	  but	  I	  feel	  really	  conflicted	  when	  those	  personal	  choices	  come	  down	  to	  a	  choice	  
between	  a	  male	  and	  female	  child.”	  (12;	  OB/GYN).	  	  
	  
12	  of	  14	  physicians	  cited	  “justice,”	  directly	  or	  indirectly,	  as	  a	  value	  or	  
concern.	  Among	  our	  participants,	  this	  principle	  was	  only	  used	  in	  the	  context	  of	  
explaining	  negative	  attitudes	  toward	  NMSS.	  Similar	  themes	  in	  this	  category	  included	  
allocation	  of	  medical	  resources,	  unequal	  access,	  and	  financial	  burden	  on	  the	  patient.	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“My	  concerns	  about	  it	  are	  mostly	  with	  distributive	  justice	  and	  the	  idea	  that	  the	  only	  
people	  who	  would	  be	  allowed	  to	  do	  that	  are	  the	  people	  who	  have	  far	  more	  money	  to	  be	  
able	  to	  afford	  it.”	  (9;	  OB/GYN).	  
	  
Another	  important	  theme	  within	  the	  principle	  of	  justice	  was	  the	  idea	  of	  
NMSS	  as	  unnecessary	  and	  a	  frivolous	  or	  irresponsible	  use	  of	  IVF	  technology.	  	  
	  
“And,	  you	  know,	  choosing	  to	  have	  one	  gender	  over	  another	  for	  some	  simple	  reason	  of,	  
again,	  like	  “I	  don’t	  want	  that,”	  does	  not	  seem	  to	  me	  to	  be	  a	  valid	  use	  of	  very	  expensive	  
and	  very	  limited	  health	  dollars,	  unless	  it’s	  coming	  from	  your	  pocket.	  And	  it’s	  not	  
something	  I	  think	  the	  technology	  was	  meant	  to	  be	  used	  for.”	  (11;	  OB/GYN).	  
	  
Nonmaleficence,	  or	  “Do	  No	  Harm”	  (as	  most	  physicians	  referred	  to	  it),	  was	  
often	  used	  to	  explain	  why	  a	  physician	  professionally	  discouraged	  NMSS	  through	  
PGD.	  Participants	  were	  most	  likely	  to	  refer	  to	  this	  principle,	  the	  basis	  for	  the	  
Hippocratic	  Oath,	  when	  discussing	  the	  physical	  risk	  of	  undergoing	  IVF,	  especially	  in	  
cases	  where	  the	  patient	  was	  otherwise	  fertile.	  	  
	  
“Well,	  I	  mean	  I	  think	  that	  it’s	  part	  of	  our	  Hippocratic	  Oath	  to	  do	  no	  harm	  and	  I	  believe	  
that	  doing	  something	  for—I	  don’t	  believe	  that	  having	  a	  child	  of	  the	  gender	  that	  you	  
want	  is	  enough	  to	  justify	  the	  harm	  of	  the	  risks	  of	  PGD	  and	  IVF,	  or	  selective	  abortion,	  et	  
cetera,	  so	  that,	  even	  though	  there	  are	  people	  who	  will	  do	  that,	  I	  think	  responsible	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physicians	  have	  to	  make	  sure	  that	  they	  follow	  that	  principle	  of	  “above	  all,	  do	  no	  harm.”	  
(3;	  OB/GYN).	  	  
	  
The	  last	  of	  the	  medical	  ethics	  principles	  is	  beneficence.	  This	  was	  infrequently	  
mentioned,	  less	  so	  than	  the	  other	  three	  principles,	  but	  used	  in	  the	  context	  of	  
wanting	  to	  help	  patients	  or	  promote	  the	  patient’s	  best	  interest.	  In	  this	  way,	  
beneficence	  was	  used	  either	  to	  justify	  supporting	  the	  patient’s	  interest	  in	  NMSS	  or	  
discouraging	  it	  in	  order	  to	  better	  serve	  the	  patient’s	  best	  interest.	  
	  
“But,	  you	  know,	  I	  just	  don’t	  believe	  in	  patient	  abandonment,	  regardless	  of	  whether	  I	  
agree	  with	  the	  issue	  or	  not.”	  (6;	  OB/GYN).	  
	  
“I	  went	  into	  this	  field	  to	  give	  patients	  that	  want	  to	  have	  children	  the	  ability	  to	  have	  
children,	  not	  the	  ability	  to	  have	  boys	  or	  girls.”	  (7;	  RE).	  	  
	  
Gender	  Equality	  	  
Though	  they	  are	  often	  interrelated,	  gender	  equality	  was	  the	  second-­‐most	  
often	  mentioned	  value	  after	  the	  medical	  ethics	  values.	  This	  was	  articulated	  by	  a	  
majority	  of	  physicians,	  almost	  equally	  among	  men	  and	  women.	  	  Physicians	  talked	  
about	  this	  value	  in	  relation	  to	  NMSS	  in	  general,	  to	  family	  balancing,	  to	  decision-­‐
making,	  and	  to	  non-­‐medical	  trait	  selection.	  This	  value	  was	  often	  cited	  when	  a	  
physician’s	  personal	  and	  professional	  beliefs	  were	  at	  odds;	  but	  when	  citing	  the	  value	  
of	  gender	  equality,	  more	  often	  than	  with	  values	  related	  to	  the	  medical	  ethics	  
	   33	  
principles,	  physicians	  let	  their	  personal	  value	  guide	  their	  professional	  
recommendations	  and	  responses.	  
	  
“I	  think	  anyone	  of	  my	  generation	  was	  sort	  of	  raising	  in	  the	  feminist-­-­	  we	  all	  have	  to	  
have	  some	  sort	  of	  female	  solidarity	  in	  getting	  each	  other,	  all	  of	  us	  to	  be	  able	  to	  be	  equal	  
to	  men,	  and	  you	  know,	  I	  think	  it’s	  very	  hard	  for	  me	  to	  detach	  that	  part	  of	  myself	  from	  
my	  feeling	  about	  [a	  couple]	  not	  wanting	  a	  girl....	  I	  just	  think	  that,	  you	  know,	  I	  can’t	  help	  
but	  want	  to	  defend	  that	  baby	  girl	  in	  that	  situation.”	  (6;	  OB/GYN).	  
	  
Personally,	  I	  find	  that	  distasteful.	  	  I	  think	  -­-­	  you	  know,	  like	  I	  said,	  as	  a	  woman,	  I	  find	  it	  
distasteful	  that	  one	  gender	  would	  be	  preferred	  over	  the	  other	  and	  probably,	  personally	  
that	  my	  other	  gender	  would	  not	  be	  preferred.	  (8;	  OB/GYN).	  
	  
POTENTIAL	  HARMS	  OF	  NMSS	  
Individual/Couple-­Level	  
There	  were	  two	  main	  harms	  expressed	  by	  physicians	  at	  the	  individual-­‐level:	  
unnecessary,	  invasive	  procedures	  and	  disappointment	  of	  parental	  expectations.	  	  
	  
But	  I	  don’t	  consider	  sex	  selection	  on	  demand	  to	  be	  a	  sufficient	  reason	  to	  take	  those	  
risks	  and	  to	  put	  patient	  autonomy	  above	  patient	  harm.	  (3;	  OB/GYN)	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“I	  think	  that	  we	  have	  huge	  expectations	  that	  aren’t	  always	  met	  and	  I	  think	  once	  you	  




In	  general,	  physicians	  were	  most	  likely	  to	  report	  “no	  harms”	  for	  themselves	  
or	  their	  colleagues	  at	  this	  level.	  However,	  they	  did	  feel	  that	  acting	  against	  one’s	  
values	  or	  code	  of	  ethics	  was	  a	  potential	  harm	  of	  allowing	  NMSS.	  
	  
“But	  there’s	  an	  implication	  on	  me	  as	  a	  provider,	  by	  doing	  something	  that	  I	  don’t	  
believe	  in,	  not	  only	  in	  terms	  of,	  in	  general,	  discriminating	  against	  the	  embryos	  that	  are	  
female,	  but	  discriminating	  against	  the	  woman	  because	  I’m	  enabling	  or	  facilitating	  the	  
male	  discrimination	  in	  that	  relationship...”	  (13;	  	  RE).	  
	  
Society/Global-­Level	  
There	  were	  two	  common	  harms	  at	  this	  level	  that	  physicians	  believed	  applied	  
to	  the	  US	  as	  well	  as	  to	  other	  countries.	  The	  first	  was	  perpetuation	  of	  gender	  
stereotypes	  and	  attendant	  sexism.	  	  Eleven	  participants	  (4	  males	  and	  7	  females)	  
spontaneously	  brought	  up	  the	  value	  of	  feminism	  or	  gender	  equality	  when	  
presenting	  their	  opinions	  on	  NMSS.	  Often	  this	  was	  in	  the	  context	  of	  being	  distressed	  
by	  the	  valuing	  of	  one	  sex	  over	  another.	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“And	  so	  because	  I’m	  sort	  of	  committed	  on	  a	  philosophical	  level	  and	  also	  in	  the	  work	  
that	  I	  do	  to	  enhance	  reproductive	  choice	  for	  women	  and	  enhance	  their	  access	  to	  care,	  I	  
think	  that	  gender	  balancing	  almost	  always	  ends	  up	  in	  discrimination	  against	  women	  
and	  the	  female	  sex.”	  (13;	  RE).	  	  	  
	  
The	  second	  harm	  discussed	  is	  the	  possibility	  of	  a	  sex	  ratio	  skew.	  Physicians	  
generally	  agreed	  that	  this	  was	  not	  currently	  a	  problem	  in	  the	  US;	  still,	  12	  of	  14	  
participants	  spontaneously	  mentioned	  the	  sex	  ratio	  when	  discussing	  population-­‐
level	  implications.	  Thus	  even	  though	  it	  was	  not	  seen	  as	  a	  currently	  pressing	  issue,	  it	  
was	  predicted	  by	  participants	  to	  be	  one	  of	  the	  most	  important	  should	  NMSS	  become	  
widespread.	  
	  
“I	  think	  there	  are	  parts	  of	  India,	  there	  are	  parts	  of	  China,	  there’re	  probably	  other	  parts	  
of	  the	  world	  in	  which	  this	  creates	  a	  real	  problem	  for	  the	  population	  because	  it	  really	  
throws	  off	  the	  number	  of	  men	  versus	  women	  in	  the	  population,	  which	  creates	  
significant	  societal	  problems.	  	  I	  think	  in	  the	  United	  States,	  we	  don’t	  have	  that	  issue,	  so,	  
in	  that	  light,	  I	  guess	  I	  don’t	  feel	  like	  it’s	  something	  that	  -­-­	  I	  wouldn’t	  offer,	  but	  I	  still	  find	  
it	  personally	  distasteful.”	  (12;	  OB/GYN).	  	  
	  
“You	  destroy	  the	  rough	  balance	  that	  exists.	  I	  mean,	  we	  know	  at	  conception,	  more	  males	  
are	  conceived,	  more	  males	  are	  born.	  But	  by	  age	  one	  and	  every	  year	  thereafter,	  there	  
are	  more	  girls	  or	  women....	  That’s	  necessary	  for	  preservation	  of	  the	  species.”	  (1;	  
OB/GYN).	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POTENTIAL	  BENEFITS	  OF	  NMSS	  
Individual/Couple-­Level	  
Physicians	  proposed	  several	  benefits	  of	  NMSS	  for	  the	  individual	  or	  couple	  
seeking	  it.	  They	  saw	  it	  as	  a	  part	  of	  family	  planning	  and	  an	  expression	  of	  reproductive	  
autonomy.	  In	  either	  family	  balancing	  or	  choosing	  the	  sex	  of	  the	  first	  child,	  they	  
acknowledged	  that	  the	  couple	  comes	  away	  with	  a	  wanted	  child	  who	  otherwise	  
wouldn’t	  exist.	  
	  
“I	  mean,	  I	  have	  to	  say	  to	  you	  that	  we	  are	  blessed,	  you	  know,	  with	  children	  of	  both	  
genders,	  and	  we	  also	  have	  many,	  many	  friends	  that	  have	  children	  of	  only	  one	  gender.	  
So	  I	  can	  clearly	  understand...the	  thrill	  of	  having,	  you	  know,	  children	  naturally	  of	  
opposite	  genders.”	  (8;	  OB/GYN).	  
	  
Provider/Profession-­Level	  
As	  with	  harms,	  physicians	  were	  less	  able	  to	  elucidate	  benefits	  of	  NMSS	  at	  the	  
provider-­‐level.	  Most	  agreed	  that	  other	  than	  satisfying	  their	  patients,	  they	  didn’t	  see	  
any	  benefits	  to	  themselves	  or	  their	  profession.	  
	  
“Other	  than	  like	  giving	  people	  what	  they	  want.	  I	  don’t	  know	  what	  the	  value	  is	  
otherwise.”	  (2;	  OB).	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Society/Global-­Level	  
On	  a	  societal-­‐level,	  one	  physician	  noted	  that	  using	  NMSS	  was	  the	  “lesser	  of	  
two	  evils”	  with	  the	  alternative	  option	  being	  termination	  of	  pregnancy.	  Otherwise,	  
our	  physicians	  were	  unable	  to	  see	  any	  benefits.	  
	  
“So	  some	  would	  argue	  that,	  well,	  it’s	  a	  lot	  -­-­	  it’s	  a	  lot	  less	  morally	  reprehensible,	  it’s	  
more	  ethical	  to	  do	  IVF	  with	  PGD	  than	  it	  is	  to	  practice,	  you	  know,	  abortions	  on	  babies	  
that	  are	  already	  in	  utero	  or	  infanticide.	  	  And	  I	  think	  that	  that’s	  probably	  true.”	  (13;	  
RE).	  
	  
VALUES	  IN	  CONFLICT	  
Twelve	  physicians	  expressed	  some	  degree	  of	  inner	  conflict	  around	  non-­‐
medical	  sex	  selection.	  Seven	  participants	  identified	  clashes	  between	  their	  values	  
around	  respect	  for	  patient	  autonomy	  and	  their	  values	  of	  justice	  or	  nonmaleficence.	  
For	  example,	  physicians	  want	  to	  respect	  their	  patients’	  desires	  while	  promoting	  
their	  best	  interests,	  but	  sometimes	  found	  the	  two	  ideals	  to	  be	  at	  odds.	  Many	  times,	  
these	  conflicts	  were	  resolved	  by	  a	  “trump,”	  meaning	  that	  the	  provider	  allowed	  one	  
of	  his/her	  values	  to	  outweigh	  another.	  	  This	  could	  work	  in	  either	  direction,	  allowing	  
the	  provider	  to	  justify	  supporting	  or	  discouraging	  their	  patients	  in	  seeking	  NMSS.	  	  
	  
“At	  the	  end	  of	  the	  day,	  I	  think	  that	  individuals,	  men	  and/or	  women,	  should	  have	  the	  
ability	  to	  reproduce	  with	  autonomy.	  I	  believe	  that.	  That	  said,	  they	  need	  to	  reproduce	  
with	  a	  sense	  of	  social	  responsibility	  and	  a	  sense	  of	  social	  justice.	  When	  you	  reproduce	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with	  a	  goal	  of	  discriminating	  on	  the	  basis	  of	  anything,	  but	  certainly	  gender,	  I	  don’t	  
think	  it	  falls	  within	  the	  boundaries	  of	  social	  justice.	  And	  that’s	  why	  I’m	  against	  it.	  So	  I	  
think	  they	  should	  have	  lots	  of	  choice,	  but	  I	  don’t	  think	  it	  should	  be	  the	  choice	  of	  
discrimination	  on	  gender.”	  (13;	  RE).	  
	  
“I’m someone who strongly believes in choice…. I wouldn’t want to restrict a woman’s 
ability to choose anything that would affect her health….And like it or not, pregnancy 
affects a woman’s health, or has the potential to affect her health. So, I’m not the person 
who should decide whether or not she can or can’t do that.  I don’t like performing 
terminations for someone on the sole basis of gender, but I know I’ve done it, sometimes 
because the patient is a little cryptic, but it’s obvious why someone’s doing it 
sometimes.” (1; OB/GYN). 
	  
There	  was	  no	  apparent	  difference	  between	  the	  two	  specialties	  in	  the	  values	  
most	  often	  in	  conflict,	  but	  OB/GYNs	  were	  more	  likely	  to	  discuss	  having	  value	  
conflicts	  at	  all	  than	  REs.	  
Another	  type	  of	  conflict,	  brought	  up	  by	  at	  least	  five	  physicians,	  referring	  
mostly	  to	  actual	  experiences	  rather	  than	  hypothetical	  ones,	  was	  the	  struggle	  
inherent	  in	  using	  NMSS	  as	  a	  solution	  for	  the	  problem	  of	  an	  individual	  patient	  and,	  in	  
doing	  so,	  reinforcing	  the	  status	  quo	  or	  propagating	  a	  larger	  social	  problem.	  Usually,	  
these	  were	  seen	  as	  paradoxical	  situations	  in	  which	  using	  NMSS	  benefitted	  the	  
individual	  while	  maintaining	  the	  societal-­‐level	  problem	  that	  had	  been	  the	  reason	  for	  
NMSS	  in	  the	  first	  place.	  Physicians	  who	  discussed	  this	  phenomenon	  expressed	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significant	  distress	  over	  it,	  either	  because	  they	  were	  concerned	  for	  the	  welfare	  of	  
their	  patient,	  or	  because	  they	  were	  unwilling	  to	  reinforce	  problematic	  social	  
structures.	  	  
For	  example,	  physicians	  often	  worried	  about	  their	  patients	  being	  subjected	  
to	  marital	  abuse	  if	  they	  had	  a	  child	  of	  the	  “wrong”	  gender.	  While	  they	  wanted	  to	  
protect	  their	  patients,	  they	  knew	  that	  NMSS	  was	  not	  actually	  helping	  the	  problem	  
and	  would	  arguably	  be	  reinforcing	  it	  on	  a	  larger	  societal	  scale.	  
	  
“Or,	  you	  know,	  ‘you’re	  going	  to	  be	  beaten	  because	  [you	  didn’t	  have	  the	  right	  gender]...’	  
you	  know,	  but	  that—I	  mean	  the	  problem	  is	  not	  the	  gender,	  the	  problem	  is	  that	  person,	  
so	  I	  don’t	  think	  [NMSS]	  is	  a	  solution.”	  (2;	  OB/GYN).	  
	  
“And	  valuing	  one	  over	  the	  other	  just	  based	  on	  gender	  is	  flawed	  because	  the	  
opportunities	  that	  are	  open	  to	  either	  gender	  have	  evolved....	  I	  feel	  it’s	  important	  that	  
every	  potential	  patient	  be	  made	  to	  realize	  that	  they	  don’t	  really	  need	  to	  choose	  one	  or	  
the	  other	  based	  on	  their	  [the	  child’s]	  chances	  of	  success.”	  (7;	  RE).	  
	  
REGULATION	  AND	  DECISION-­MAKING	  	  
Physicians	  were	  asked	  to	  consider	  who	  is	  responsible	  for	  NMSS	  at	  their	  place	  
of	  work,	  who	  they	  felt	  should	  have	  the	  power	  to	  make	  NMSS-­‐related	  decisions,	  and	  
what	  kind	  of	  policy	  they	  themselves	  would	  institute	  if	  given	  the	  opportunity.	  All	  
physicians	  said	  that	  the	  current	  method	  of	  decision-­‐making	  at	  their	  place	  of	  work	  
was	  adequate.	  The	  majority	  of	  NMSS-­‐related	  decisions	  are	  made	  by	  individual	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physicians	  or	  the	  providers	  of	  one	  institution	  making	  decisions	  as	  a	  group.	  Some	  
were	  uncertain	  of	  the	  policies	  where	  they	  worked	  and	  several	  reported	  there	  was	  
no	  official	  policy.	  	  
As	  to	  who	  or	  what	  the	  physicians	  would	  ideally	  prefer,	  there	  was	  a	  lot	  of	  
uncertainty	  and	  several	  answers	  that	  included	  contradictions.	  Many	  of	  our	  
physicians	  believed	  that	  NMSS	  should	  be	  regulated	  by	  a	  professional	  society,	  like	  
ASRM,	  yet	  didn’t	  feel	  that	  that	  was	  a	  realistic	  or	  truly	  preferable	  solution.	  They	  felt	  
that	  an	  issue	  that	  could	  have	  population-­‐level	  effects	  or	  cause	  harm	  to	  society	  
should	  be	  in	  the	  purview	  of	  the	  professional	  societies.	  Simultaneously,	  they	  worried	  
that	  a	  societal	  or	  governmental	  policy	  would	  be	  rigid	  and	  interfere	  with	  the	  
evolution	  of	  the	  technology	  as	  well	  as	  the	  patient-­‐provider	  relationship.	  They	  also	  
felt	  that	  the	  professional	  societies	  were	  unlikely	  to	  take	  a	  position	  on	  a	  controversial	  
topic	  unless	  an	  extreme	  problem	  surfaced,	  like	  a	  significant	  sex	  ratio	  skew.	  	  
	  
“I	  think	  it	  makes	  all	  of	  our	  lives	  much	  easier,	  if	  we	  have	  a	  professional	  society	  passing	  
down	  a	  guideline.	  On	  an	  issue	  as	  sensitive	  as	  this,	  I	  just	  don’t	  see	  that	  happening....	  it	  
ultimately	  is	  very	  often	  left	  to	  the	  individual	  provider,	  which	  I	  think	  is	  much	  harder.”	  
(6;	  OB/GYN).	  
	  
“It	  would	  be	  nice	  if	  the	  medical	  society	  came	  up	  with	  a	  consensus	  statement,	  but	  
there’s	  so	  many	  viewpoints	  to	  take	  into	  account.”	  (7;	  RE).	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“I	  think	  the	  professional	  society	  should	  probably	  have	  some	  sort	  of	  involvement	  in	  this	  
and	  generally	  when	  things	  are	  decided	  at	  that	  level	  there’s	  a	  uniform	  practice	  across	  
the	  nation.	  And	  then,	  you	  know,	  you	  can	  keep	  things	  in	  check.”	  (5;	  RE).	  
	  
However,	  simultaneously,	  most	  did	  not	  want	  regulations	  from	  a	  professional	  
society	  or	  government	  body	  that	  would	  restrict	  the	  physician’s	  judgment.	  	  The	  type	  
of	  decision-­‐making	  that	  physicians	  found	  most	  ideal	  was	  joint	  decision-­‐making	  
between	  the	  patient	  and	  provider.	  	  
	  
“I	  don’t	  think	  there	  should	  be	  an	  organization,	  because	  anytime	  one	  has	  
administrators	  making	  medical	  decisions,	  it’s	  anathema	  to	  my	  personal	  beliefs.	  	  I	  think	  
physicians	  should	  make	  medical	  decisions	  in	  concert	  with	  their	  patients,	  not	  have	  some	  
legislator	  decide	  what	  should	  be	  done	  just	  based	  on	  whatever	  ideological	  beliefs	  that	  
legislator	  has.	  	  I	  think	  one	  of	  the	  big	  problems	  in	  medicine	  is	  that	  you	  have	  individuals	  
who	  have	  no	  medical	  experience	  other	  than	  going	  to	  the	  doctor,	  making	  decisions.	  	  So,	  
in	  general,	  it	  should	  be	  left	  to	  the	  patient	  and	  her	  physician.”	  (1;	  OB/GYN).	  
	  
When	  asked	  what	  policy	  they	  would	  prefer,	  several	  physicians	  favored	  a	  total	  
ban	  on	  NMSS,	  while	  others	  preferred	  less	  restrictive	  regulation.	  A	  few	  physicians	  
compared	  NMSS	  to	  cosmetic	  surgery	  and	  preferred	  that	  it	  be	  legal	  so	  long	  as	  the	  
financial	  burden	  was	  on	  the	  patient,	  not	  the	  insurance.	  A	  small	  minority	  were	  so	  
uncertain	  that	  they	  were	  unable	  to	  express	  a	  preference;	  often	  this	  was	  because	  
they	  didn’t	  know	  how	  their	  colleagues	  felt	  about	  NMSS.	  One	  OB/GYN	  suggested	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monitoring	  the	  number	  of	  males	  and	  females	  born	  through	  NMSS	  and	  stepping	  in	  
only	  if	  the	  ratio	  strayed	  too	  far	  from	  the	  norm.	  
	  
GATEKEEPING	  
Most	  of	  the	  physicians	  were	  asked	  whether	  they	  felt	  themselves	  or	  their	  
colleagues	  to	  be	  in	  the	  position	  of	  “gatekeeper”	  to	  the	  technology	  of	  NMSS	  via	  PGD.	  
Twice	  as	  many	  physicians	  said	  yes	  as	  said	  no,	  with	  some	  answering	  both	  yes	  and	  no;	  
one	  spontaneously	  created	  the	  term	  “gate	  regulator”	  which	  he	  felt	  to	  be	  more	  
accurate.	  All	  those	  who	  didn’t	  identify	  with	  the	  gatekeeping	  role	  identified	  the	  
patients	  as	  gatekeepers,	  for	  several	  reasons.	  Patients,	  they	  said,	  could	  always	  search	  
until	  they	  found	  a	  doctor	  who	  would	  do	  the	  procedure.	  Additionally,	  almost	  all	  
physicians	  who	  would	  not	  or	  could	  not	  perform	  NMSS	  referred	  their	  patients	  
elsewhere	  and	  didn’t	  actively	  try	  to	  stop	  their	  seeking	  it.	  Finally,	  physicians	  
protested	  that	  they	  should	  not	  be	  encroaching	  on	  patient	  autonomy,	  thus	  making	  it	  
impossible	  for	  them	  to	  be	  gatekeepers.	  
	  
“I	  think	  the	  patient	  is	  her	  own	  gatekeeper.	  It’s	  a	  question	  of	  whether	  or	  not	  we	  open	  it	  
sufficiently	  for	  her	  or	  provide	  her	  other	  avenues	  or	  other	  entrances	  through	  the	  gate....	  
So	  physicians	  are	  not	  necessarily	  the	  gate	  keepers.	  They	  might	  be	  the	  ‘gate	  
regulators’.”	  (1;	  OB/GYN)	  
	  
“I	  think	  that	  doctors	  shouldn’t	  be	  gatekeepers.	  If	  they	  perform	  the	  procedure	  and	  they	  
can	  do	  it	  safely	  and	  accurately,	  the	  patient	  should	  be	  the	  driver.”	  (8;	  OB/GYN).	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Those	  who	  identified	  with	  the	  gatekeeping	  role	  saw	  their	  role	  as	  one	  of	  
responsibility;	  they	  needed	  to	  be	  gatekeepers	  in	  order	  to	  uphold	  the	  principle	  of	  “do	  
no	  harm.”	  One	  participant	  acknowledged	  that	  she	  would	  refuse	  certain	  patients	  
because	  their	  age	  made	  the	  chances	  of	  success	  so	  low	  that	  she	  felt	  it	  was	  unethical	  to	  
allow	  them	  to	  go	  through	  the	  procedure.	  
	  
“Sometime	  we	  have	  to	  [gatekeep]—I	  feel	  like	  I’m	  a	  protector,	  almost,	  of	  them	  from	  
themselves.”	  (4;	  RE).	  	  
	  
At	  least	  one	  OB/GYN	  felt	  REs	  were	  in	  the	  gatekeeping	  role	  because	  they	  
could	  actually	  provide	  the	  technology.	  Another	  participant	  identified	  strongly	  with	  
the	  gatekeeping	  role,	  but	  acknowledged	  that	  her	  colleagues	  felt	  less	  strongly	  about	  
discouraging	  NMSS	  and	  were	  therefore	  not	  gatekeepers	  in	  the	  same	  sense	  that	  she	  
was.	  
	  
NON-­MEDICAL	  TRAIT	  SELECTION	  
Non-­‐medical	  trait	  selection	  was	  discussed	  in	  the	  context	  of	  NMSS	  as	  the	  first	  
non-­‐medical	  use	  of	  PGD.	  Physicians	  were	  asked	  which	  traits	  were	  appropriate	  for	  
non-­‐medical	  trait	  selection,	  and	  more	  importantly,	  how	  they	  drew	  the	  line	  between	  
appropriate	  and	  not.	  They	  were	  also	  asked	  whether	  they	  felt	  that	  NMSS	  was	  
fundamentally	  different	  from	  non-­‐medical	  trait	  selection	  (NMTS).	  Three	  physicians	  
spontaneously	  used	  the	  phrase	  “slippery	  slope”	  in	  reference	  to	  their	  concern	  that	  
	   44	  
NMSS	  would	  inevitably	  lead	  to	  NMTS.	  Of	  the	  14	  physicians,	  12	  were	  decidedly	  
opposed	  to	  non-­‐medical	  trait	  selection	  (NMTS)	  for	  several	  reasons.	  Nature	  was	  a	  
major	  theme	  in	  the	  discussion	  around	  NMTS;	  the	  importance	  of	  evolution	  was	  
frequently	  invoked	  to	  explain	  that	  NMTS	  would	  interfere	  with	  natural	  selection.	  
	  
“So	  no,	  I	  don’t	  think	  any	  nonmedical	  physical	  traits,	  for	  example,	  need	  to	  be	  selected	  for	  
because	  it’s	  our	  heterogeneity	  that	  keeps	  the	  species	  strong.”	  (7;	  RE)	  
	  
Another	  common	  response	  was	  a	  concern	  about	  the	  potential	  for	  unknown	  
traits	  to	  be	  “piggybacking”	  on	  selected	  traits.	  Given	  that	  the	  majority	  of	  genes	  are	  
still	  poorly	  understood,	  physicians	  were	  concerned	  that	  selecting	  one	  particular	  
trait	  would	  affect	  other	  traits	  through	  gene	  linkages	  and	  perceived	  this	  uncertainty	  
as	  an	  unacceptable	  risk.	  
	  
“I	  think	  what	  the	  danger	  is,	  is	  that	  when	  we	  are	  trying	  to	  select	  for	  and	  against	  sort	  of	  
non-­medically	  indicated	  traits,	  we	  really	  don’t	  have	  any	  idea	  what	  other	  things	  could	  
be	  found	  on	  those	  same	  genes.	  What	  other	  things	  we	  might	  actually	  be	  selecting	  into	  
our	  population,	  which	  in	  turn	  I	  would	  think	  would	  be	  very	  dangerous.”	  (12;	  OB/GYN).	  	  
	  
The	  two	  physicians	  who	  were	  not	  opposed	  to	  NMTS,	  as	  well	  as	  some	  who	  
were,	  agreed	  that	  a	  similar	  phenomenon	  had	  been	  in	  existence	  for	  25-­‐30	  years	  
already,	  through	  donor	  gamete	  selection.	  Because	  couples	  could	  select	  donors	  based	  
	   45	  
on	  traits	  like	  physical	  features	  and	  intelligence,	  NMTS	  via	  PGD	  was	  seen	  as	  a	  natural	  
extension	  of	  gamete	  selection.	  
	  
“I	  mean,	  I	  think	  it’s	  no	  different	  than	  a	  woman	  picking	  a	  sperm	  donor	  out	  of	  a	  book.”	  
(8;	  OB/GYN).	  
	  
Additionally,	  physicians	  were	  asked	  whether	  they	  had	  experience	  with	  
patients	  requesting	  non-­‐medical	  traits	  and	  whether	  they	  felt	  their	  patients	  would	  
request	  them	  once	  it	  became	  a	  scientific	  possibility.	  Most	  physicians	  found	  the	  
hypothetical	  idea	  of	  NMTS	  to	  be,	  not	  only	  realistic,	  but	  also	  problematic.	  Physicians	  
said	  that	  some	  patients	  would	  joke	  about	  the	  idea	  or	  ask	  if	  it	  were	  a	  possibility	  but	  
no	  patients	  had	  come	  in	  asking	  seriously	  about	  a	  specific	  trait.	  
	  
“I	  think	  that	  [NMTS]	  will	  likely	  come,	  but	  I	  think	  the	  moral	  and	  ethical	  and	  social	  
discourse	  on	  this	  needs	  to	  precede	  the	  application	  of	  the	  technology.	  That	  said,	  I	  think	  
we	  have	  to	  stay	  constantly	  vigilant	  about	  the	  technologies	  and	  how	  they’re	  applied	  
and	  I	  think	  family	  balancing,	  gender	  selection	  is	  a	  very	  slippery	  slope.”	  (13;	  RE).	  	  
	  
“And	  again,	  like	  people	  are	  people,	  and	  we	  need	  to	  embrace	  those	  differences,	  and	  not	  
try	  to	  eliminate	  them	  and	  the	  whole	  eugenics	  thing	  and	  -­-­	  	  yes,	  not	  okay.”	  (2;	  OB/GYN).	  
	  
Finally,	  physicians	  discussed	  how	  NMSS	  was	  the	  same	  as	  or	  different	  from	  
NMTS.	  Most	  physicians	  felt	  that	  both	  NMTS	  and	  NMSS	  were	  equally	  unacceptable,,	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that	  they	  would	  respond	  in	  the	  same	  way—by	  referring	  the	  patient	  elsewhere—and	  
most	  drew	  their	  ethical	  line	  at	  medical	  necessity,	  thereby	  concluding	  that	  no	  traits	  
were	  appropriate	  for	  NMTS.	  Others	  saw	  the	  two	  as	  different.	  Interestingly,	  the	  
physicians	  who	  felt	  they	  were	  fundamentally	  different	  were	  divided	  on	  which	  type	  
of	  selection	  they	  thought	  was	  more	  problematic.	  	  
	  
“I	  think	  the	  difference	  is	  in	  the	  history	  of	  oppression	  of	  women....	  It	  carries	  more	  
weight.	  I	  think	  the	  male/female	  thing	  carries	  more	  weight	  than	  just	  eye	  color	  or	  height	  
or	  intelligence.”	  (9;	  OB/GYN).	  
	  
“Just	  because	  I	  have	  more	  money,	  I	  shouldn’t	  be	  able	  to	  pay	  for	  a	  taller,	  or	  more	  
intelligent,	  or	  more	  musical,	  or	  blue-­eyed,	  or	  a...	  whatever	  child....	  The	  implications	  are	  
racism	  and	  classism	  and,	  frankly,	  forming	  caste	  systems.”	  (9;	  OB/GYN).	  	  
	  
One	  physician,	  in	  talking	  about	  her	  role	  in	  non-­‐medical	  sex	  or	  trait	  selection	  
explained	  that	  where	  she	  drew	  the	  line	  was	  problematic	  because	  society	  and	  
technology	  are	  constantly	  evolving.	  
	  
“You	  know	  I’d	  like	  to	  say	  that	  I	  kind	  of	  limit	  it	  to	  medical	  indications	  although	  I	  really	  
understand	  that	  that’s	  a	  flawed	  answer	  because	  medicine	  evolves	  constantly.	  You	  
know,	  there	  might	  be	  a	  time	  in	  the	  future	  that	  all	  of	  these	  like	  specific	  phenotypic	  
things	  are	  considered	  medical.”	  (6;	  OB/GYN).	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NMSS	  AND	  PARENTING	  NORMS	  
Whether	  they	  were	  parents	  or	  not,	  many	  physicians	  made	  statements	  about	  
parenting	  values	  and	  norms.	  Often	  this	  included	  the	  idea	  that	  a	  parent	  should	  want	  a	  
healthy	  child	  rather	  than	  wanting	  a	  particular	  sex.	  
	  
“I	  think	  both	  sexes	  should	  be	  fine	  for	  your	  child,	  for	  your	  first	  child.	  You	  know,	  as	  long	  
as	  your	  child	  is	  hopefully	  healthy...	  I	  don’t—I	  find	  [NMSS	  for	  a	  first	  child]	  personally	  
not	  acceptable.”	  (4;	  RE).	  
	  
Overall,	  the	  majority	  of	  physicians	  were	  against	  NMSS	  for	  family	  balancing.	  
For	  almost	  all	  physicians,	  NMSS	  for	  a	  first	  child	  was	  just	  as,	  if	  not	  more	  distasteful,	  
than	  for	  family	  balancing	  because	  it	  implied	  an	  inherent	  value	  in	  one	  gender	  over	  
the	  other	  and	  was,	  physicians	  felt,	  based	  on	  gender	  stereotypes.	  Some	  physicians	  
suggested	  that,	  in	  the	  case	  of	  first	  children,	  parents	  may	  believe	  that	  they	  have	  a	  
gender	  preference,	  but	  they	  don’t	  know	  enough	  about	  the	  parenting	  experience	  to	  
know	  that	  for	  certain.	  
	  
“If	  it’s	  your	  first	  kid	  you	  don’t	  know	  what	  to	  expect	  so	  why	  would	  you	  want	  one	  sex	  
over	  the	  other?....	  you	  may	  want	  one	  gender	  for	  a	  first	  child,	  but	  then	  you	  actually	  have	  
the	  other	  gender,	  you’re—you	  know,	  may	  like	  that	  more	  or	  something.”	  (5;	  RE).	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Additionally,	  physicians	  expressed	  their	  impression	  that	  parents	  expect	  
something	  specific	  of	  a	  “balanced	  family”	  that	  may	  have	  more	  to	  do	  with	  gender	  
stereotypes.	  	  
	  
No,	  I	  think	  a	  lot	  of	  people	  see	  a	  value	  in	  a	  family	  with	  balance,	  where,	  you	  know,	  there’s	  
a	  mom	  and	  a	  dad,	  and	  there’s	  a	  daughter	  and	  a	  son.	  	  But	  you	  know,	  again	  though	  you	  
get	  into	  sexual	  stereotypes.	  	  They	  see	  the	  daughter	  with	  a	  Barbie	  doll	  and	  they	  see	  the	  
son	  with	  a	  baseball	  bat	  or	  whatever.	  (13;	  RE).	  
	  
Physicians	  also	  valued	  the	  ideal	  of	  parents	  who	  accepted	  their	  children	  for	  
who	  they	  are.	  There	  was	  a	  concern	  that	  parents	  were	  using	  technology	  to	  try	  to	  
control	  aspects	  of	  their	  parenting	  experience	  that	  were	  truly	  beyond	  their	  control	  
and	  that	  this	  would	  ultimately	  lead	  to	  unrealistic	  expectations	  and	  disappointment.	  	  	  
	  
“I	  think	  that	  an	  inherent	  part	  of	  parenthood	  is	  that	  you	  have	  to	  understand	  that	  you	  
cannot	  be	  in	  control	  of	  everything.	  That	  is	  the	  nature	  of	  the	  human	  condition,	  and	  it	  is	  
what	  parenthood	  maybe	  teaches	  better	  than	  anything	  else.”	  (6;	  OB/GYN).	  
	  
“Because	  it’s	  not	  about	  being	  a	  happy	  parent.	  	  It’s	  about	  being	  a	  happy	  parent	  
contingent	  on	  a	  specific	  outcome,	  which	  just	  {sets	  up	  the}	  dynamic	  where	  that	  child	  
will	  sometimes	  disappoint	  that	  parent	  who	  has	  an	  expectation	  of	  perfection	  and	  it	  will	  
be	  taken	  out	  on	  that	  child.	  And	  I	  just	  think	  that	  coming	  into	  parenthood	  with	  that	  
mindset	  that	  I	  can	  create	  the	  perfect	  child	  is	  dooming	  that	  kid	  {to	  never	  being	  able	  to	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live	  up	  to}	  whatever	  the	  expectation	  will	  be,	  and	  I	  just	  don’t	  think	  that	  that	  kind	  of	  
psychological	  trauma	  is	  {ever	  worth}	  whatever	  phenotype	  that	  the	  parent	  is	  looking	  
for.”	  (6;	  OB/GYN).	  	  
	  
Similarly,	  participants	  discussed	  the	  importance	  of	  valuing	  people’s	  
differences,	  specifically	  parents	  valuing	  the	  unique	  qualities	  of	  their	  children.	  This	  
norm	  came	  up	  most	  often	  in	  response	  to	  non-­‐medical	  trait	  selection.	  	  
	  	  
“We	  need	  all	  kinds	  of	  people	  in	  this	  world,	  and	  designing	  your	  child...	  to	  be	  perfect,	  or	  
whatever	  you	  think	  is	  perfect,	  just	  makes	  for	  a	  very	  boring	  society.”	  (11;	  OB/GYN)	  
	  
“I	  mean,	  why	  would	  you	  want	  to	  have	  everybody	  have	  blue	  eyes,	  or	  everybody	  be	  
brilliant,	  you	  know?	  ....	  I	  think	  variety	  is	  the	  spice	  of	  life.”	  (4;	  RE).	  	  
	  
Valuing	  the	  differences	  among	  people	  was	  also	  held	  up	  as	  important	  so	  that	  
certain	  traits	  would	  not	  be	  considered	  inferior	  to	  others.	  
	  
“I	  mean	  [trait	  selection]	  devalues	  the	  majority	  of	  other	  human	  beings	  that	  aren’t	  of	  
that	  trait.”	  (4;	  RE).	  	  
	  
Of	  our	  participants,	  12	  of	  14	  were	  parents	  themselves	  and	  about	  half	  cited	  
their	  experiences	  with	  parenthood	  as	  a	  value	  that	  affected	  their	  attitudes	  toward	  
NMSS	  for	  family	  balancing.	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“And	  so,	  we’ll	  have	  people	  who	  come	  to	  do	  gender	  selection	  because	  they’ve	  had	  girls	  
and	  they	  culturally	  wanted	  to	  have	  a	  boy.	  Somehow,	  being	  female	  and	  having	  two	  
daughters,	  you	  know,	  I	  feel	  uncomfortable	  with	  that.”	  (14;	  RE).	  
	  
CULTURE	  AND	  ETHNICITY	  
	  
Though	  we	  didn’t	  ask	  about	  the	  sex	  ratio	  or	  cultural	  preferences,	  a	  word	  
query	  in	  NVivo	  revealed	  that	  “ethnicity”	  and	  “culture”	  came	  up	  in	  all	  but	  two	  of	  the	  
interviews.	  Some	  physicians	  seemed	  reluctant	  or	  uncomfortable	  to	  discuss	  cultural	  
differences,	  even	  though	  they	  brought	  up	  the	  topic	  spontaneously,	  and	  most	  seemed	  
conflicted	  on	  the	  topic;	  they	  wanted	  to	  respect	  a	  couple’s	  cultural	  values,	  but	  didn’t	  
want	  to	  propagate	  harmful	  ideas	  about	  gender	  or	  contribute	  to	  a	  ratio	  skew.	  
	  
"I	  don't	  support	  the	  concept	  of	  male	  gender	  preference.	  I	  believe	  that	  people	  have	  a	  
right	  to	  do	  what	  they	  want	  to	  do	  culturally	  but	  it's	  not	  something	  that	  I	  support	  
personally.	  (3;	  OB/GYN)	  
	  
"I	  find	  it	  challenging	  because	  in	  my	  patient	  population,	  which	  is	  largely	  underserved	  
and	  immigrant	  populations,	  the	  only	  people	  that	  I've	  had	  ask	  for	  sex	  selection	  are	  
people	  who	  are	  asking	  for	  male	  children.	  And	  that	  tends	  to	  be	  a	  cultural	  bias	  against	  
having	  female	  children,	  which	  as	  a	  woman	  myself,	  I	  find	  somewhat	  offensive,	  and	  I	  try	  
to	  separate	  my	  personal	  feelings	  from	  my	  ability	  to	  deal	  with	  my	  patients."	  (12;	  
OB/GYN).	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"I	  don't	  agree	  with	  the	  cultures	  that	  say	  it's	  fine	  to	  do	  this.	  But	  the	  reality	  of	  it	  is,	  more	  
than	  half	  the	  people	  on	  the	  face	  of	  the	  earth	  live	  in	  societies	  and	  cultures	  where	  this	  is	  
completely	  expected.	  I	  mean	  they	  don't	  even	  question	  it.	  Over	  half	  the	  people	  on	  the	  
planet	  wouldn't	  even	  question	  it."	  (13;	  RE).	  
	  
DISCUSSION	  
The	  purpose	  of	  this	  study	  was	  to	  explore	  and	  describe	  physicians’	  
experiences	  of	  and	  attitudes	  toward	  non-­‐medical	  sex	  selection	  via	  PGD.	  Hunt	  and	  
Carnevale’s	  Moral	  Experience	  Framework	  was	  used	  in	  order	  to	  underscore	  the	  
nuances	  of	  physicians’	  experiences,	  as	  well	  as	  the	  direction	  and	  depth	  of	  their	  
feelings,	  particularly	  around	  ethical	  issues.	  The	  study	  also	  sought	  to	  explore	  
physicians’	  perceptions	  of	  implications,	  ethical	  or	  otherwise,	  at	  multiple	  levels.	  The	  
third	  goal	  was	  to	  explore	  how	  physicians	  currently	  make	  decisions	  around	  NMSS	  
and	  what	  role,	  if	  any,	  they	  preferred	  to	  play	  in	  the	  decision-­‐making	  process	  
recognizing	  that	  they	  may	  be	  ideally	  placed	  to	  be	  gatekeepers	  of	  the	  technology.	  
Finally,	  this	  study	  attempted	  to	  elicit	  the	  perceived	  appropriateness	  of	  other	  non-­‐
medical	  traits	  for	  PGD,	  how	  physicians	  drew	  those	  lines,	  and	  whether	  their	  attitudes	  
mirrored	  or	  diverged	  from	  those	  around	  NMSS.	  Analysis	  of	  the	  data	  revealed	  
nuanced	  attitudes	  toward	  NMSS	  and	  non-­‐medical	  trait	  selection	  (NMTS)	  as	  well	  as	  
perceived	  benefits	  and	  harms	  on	  multiple	  levels.	  Other	  themes	  included	  the	  specific	  
values	  that	  drove	  physicians’	  attitudes,	  as	  well	  as	  a	  high	  level	  of	  ambivalence	  around	  
decision-­‐making	  and	  gatekeeping.	  The	  data	  from	  these	  interviews	  revealed	  complex	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attitudes	  and	  the	  values	  behind	  them,	  values	  conflicts	  and	  decision-­‐making	  
paradoxes,	  and	  ambivalence	  that	  prevented	  the	  physicians	  in	  this	  study	  from	  easily	  
“drawing	  lines.”	  	  These	  findings	  underscore	  the	  existence	  and	  importance	  of	  ethical	  
struggles	  among	  physicians	  and	  have	  implications	  for	  clinical	  practice	  as	  well	  as	  
professional	  society	  regulation.	  
	  
ATTITUDES	  AND	  VALUES	  
Autonomy	  and	  Other	  Values	  
According	  to	  the	  American	  Society	  of	  Reproductive	  Medicine	  (ASRM),	  the	  
right	  to	  reproductive	  freedom	  is	  not	  an	  absolute	  right,	  but	  limitations	  must	  have	  
significant	  justification.	  This	  perfectly	  captures	  the	  most	  common	  reason	  for	  
physicians	  to	  have	  a	  values	  conflict	  or	  ethical	  dilemma.	  Patient	  autonomy	  is	  
frequently	  held	  in	  higher	  regard	  than	  the	  other	  medical	  ethics	  principles	  despite	  the	  
principles	  being	  theoretically	  equal.	  Evidently,	  some	  of	  the	  physicians	  in	  our	  study	  
struggled	  to	  reconcile	  autonomy	  with	  other	  values,	  especially	  justice	  and	  
nonmaleficence,	  which	  is	  significant	  because	  no	  single	  ethical	  principle	  should	  
outweigh	  another	  (Puri	  &	  Nachtigall,	  2010).	  Most	  of	  these	  conflicts	  could	  only	  be	  
resolved	  with	  a	  “trump,”	  when	  the	  physician	  chose	  one	  value	  to	  outweigh	  the	  other.	  
Physicians	  also	  expressed	  distress	  when	  they	  found	  themselves	  in	  the	  position	  of	  
making	  a	  decision	  in	  a	  lose-­‐lose	  or	  paradoxical	  situation;	  these	  were	  the	  scenarios	  of	  
site-­‐specific	  benefit	  with	  negative	  status	  quo	  maintenance.	  
Stern	  et	  al	  (2003)	  qualitatively	  studied	  fertility	  clinic	  directors’	  reactions	  to	  
ethically	  complex	  cases,	  one	  of	  which	  was	  a	  request	  for	  NMSS	  for	  family	  balancing.	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Those	  directors	  who	  believed	  in	  denying	  NMSS	  did	  so	  on	  the	  basis	  of	  their	  
philosophy	  of	  medicine;	  this	  closely	  mirrors	  the	  value	  of	  medical	  ethics	  principles	  
that	  physicians	  relied	  on	  for	  decision-­‐making	  in	  this	  study.	  For	  example,	  clinic	  
directors	  were	  concerned	  about	  misuse	  of	  the	  technology	  or	  its	  use	  for	  non-­‐disease	  
conditions,	  both	  justice-­‐related	  considerations,	  also	  brought	  up	  by	  the	  physicians	  in	  
our	  study.	  Furthermore,	  some	  clinic	  directors	  felt	  NMSS	  was	  unethical	  or	  a	  “slippery	  
slope”	  to	  other	  inappropriate	  uses	  of	  technology.	  Clinic	  directors	  who	  conceded	  to	  
use	  NMSS	  in	  this	  hypothetical	  case	  cited	  patient	  autonomy	  as	  the	  primary	  
determinant	  even	  if	  they	  believed	  that	  the	  treatment	  shouldn’t	  occur.	  Likewise,	  
though	  most	  physicians	  in	  our	  study	  identified	  themselves	  as	  against	  NMSS,	  the	  vast	  
majority	  would	  support	  a	  patient	  who	  wanted	  to	  use	  it	  out	  of	  respect	  for	  patient	  
autonomy.	  	  
Clinic	  directors,	  in	  making	  decisions	  about	  NMSS,	  also	  discussed	  
discrimination	  and	  the	  potential	  impact	  of	  this	  technology	  on	  the	  sex	  ratio	  and	  on	  a	  
woman’s	  place	  in	  society	  (Stern	  et	  al,	  2003).	  Gender	  equality	  was	  a	  commonly	  cited	  
value	  after	  medical	  ethics	  and	  also	  complicated	  NMSS	  for	  our	  physicians.	  Concern	  
over	  the	  sex	  ratio	  and	  the	  propagation	  of	  sexism	  (in	  the	  form	  of	  gender	  roles	  and	  
stereotypes)	  were	  the	  two	  greatest	  harms	  of	  NMSS	  mentioned	  by	  physicians	  in	  our	  
current	  study.	  	  The	  current	  study	  extended	  Stern	  et	  al’s	  2003	  study	  by	  eliciting	  non-­‐
hypothetical	  experiences	  in	  addition	  to	  hypothetical	  thought	  experiments.	  
Furthermore,	  in	  our	  study	  physicians	  were	  asked	  about	  selection	  for	  a	  first	  child,	  the	  
reactions	  to	  which	  may	  have	  been	  based	  on	  different	  values	  than	  those	  identified	  by	  
the	  clinic	  directors.	  Finally,	  Stern	  et	  al’s	  study	  was	  almost	  80%	  male	  while	  this	  study	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is	  nearly	  50%	  male;	  if	  the	  genders	  do	  have	  fundamental	  differences	  in	  attitudes,	  
then	  our	  study	  was	  better	  positioned	  to	  capture	  that.	  
Puri	  and	  Nachtigall’s	  2010	  study	  compared	  the	  attitudes	  and	  experiences	  of	  
primary	  care	  physicians	  (including,	  but	  not	  limited	  to,	  OB/GYNS)	  and	  physician	  
providers	  of	  clinical	  sex	  selection	  services	  (REs).	  Once	  again,	  medical	  ethics	  values	  
emerged	  as	  the	  main	  predictors	  of	  attitudes	  and	  behaviors.	  Whereas	  in	  our	  study,	  
there	  were	  seemingly	  no	  differences	  in	  the	  values	  or	  attitudes	  of	  OB/GYNS	  and	  REs,	  
Puri	  and	  Nachtigall	  saw	  distinctly	  different	  perceptions	  of	  these	  values	  in	  their	  two	  
physician	  groups.	  In	  part,	  this	  may	  have	  been	  because	  their	  group	  of	  PCPs	  included	  
OB/GYNs,	  family	  medicine	  physicians,	  and	  pediatricians,	  which	  may	  have	  made	  the	  
two	  groups	  more	  distinct	  or	  polarized	  in	  their	  opinions.	  Additionally,	  Puri	  and	  
Nachtigall	  reported	  theoretical	  saturation	  within	  the	  PCP	  group,	  though	  not	  the	  RE	  
group,	  and	  the	  current	  study	  may	  have	  different	  findings	  when	  more	  physicians	  are	  
interviewed.	  Of	  the	  medical	  ethics	  principles,	  autonomy	  was	  a	  primary	  theme	  in	  
both	  studies;	  in	  fact,	  it	  was	  the	  most	  commonly	  cited	  argument	  both	  for	  and	  against	  
sex	  selection.	  Puri	  and	  Nachtigall’s	  REs	  saw	  NMSS	  as	  an	  expressive	  of	  reproductive	  
rights	  and	  female	  empowerment.	  Their	  sample	  of	  primary	  care	  providers	  (PCPs)	  felt	  
that	  patient	  autonomy	  was	  compromised	  by	  complex,	  outside	  factors,	  especially	  
social	  forces,	  that	  unduly	  influenced	  women’s	  decisions	  around	  NMSS.	  	  
In	  our	  study,	  autonomy	  was	  almost	  always	  used	  in	  the	  context	  of	  supporting	  
NMSS,	  but	  it	  was	  the	  ethical	  principle	  and	  value	  that	  seemed	  most	  likely	  to	  create	  
conflict	  for	  physicians.	  In	  Puri	  and	  Nachtigall,	  the	  PCPs	  questioned	  whether	  the	  
legality	  of	  abortion	  “conferred	  legitimacy	  on	  all	  reproductive	  choice.”	  Similarly,	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physicians	  in	  our	  study	  who	  voiced	  a	  commitment	  to	  women’s	  reproductive	  
autonomy,	  or	  pro-­‐choice	  values,	  struggled	  when	  they	  felt	  that	  respecting	  a	  woman’s	  
choice	  was	  not	  in	  her	  best	  interest.	  Interestingly,	  it	  seems	  as	  though	  the	  opposing	  
views	  that	  Puri	  and	  Nachtigall’s	  groups	  held	  were	  those	  that	  were	  simultaneously	  
held	  by	  many	  physicians	  in	  our	  study,	  contributing	  to	  discrepancies	  between	  
personal	  and	  professional	  beliefs	  as	  well	  as	  values	  conflicts.	  	  	  
	  
Family	  Balancing	  and	  First	  Children	  
On	  family	  balancing,	  the	  ASRM	  guidelines	  say	  that	  it	  is	  not	  unethical	  for	  
parents	  to	  have	  a	  child	  “of	  the	  gender	  opposite	  to	  that	  of	  an	  existing	  child	  or	  
children,”	  which	  is	  in	  line	  with	  the	  actions,	  if	  not	  the	  beliefs,	  of	  most	  of	  our	  
providers.	  However,	  the	  ASRM	  says	  of	  selecting	  for	  a	  first	  child	  that	  it	  “would	  not	  be	  
unethical	  for	  parents	  to	  prefer	  that	  their	  first-­‐born	  or	  only	  child	  be	  of	  a	  particular	  
gender	  because	  of	  the	  different	  meaning	  and	  companionship	  experiences	  that	  they	  
expect	  to	  have.”	  This	  runs	  counter	  to	  the	  attitudes	  of	  most	  physicians	  in	  our	  study	  
who	  believed	  that	  selection	  for	  a	  first	  child	  was	  less	  acceptable,	  less	  of	  a	  necessity,	  
and	  based	  more	  on	  gender	  roles	  and	  stereotypes.	  Puri	  and	  Nachtigall’s	  SSTPs	  did	  
not	  feel	  it	  was	  within	  their	  purview	  to	  ask	  patients	  the	  reason	  for	  social	  sex	  
selection.	  	  
Unlike	  Puri	  and	  Nachtigall’s	  PCPs,	  physicians	  in	  our	  study	  did	  not	  discuss	  the	  
possible	  effects	  of	  NMSS	  on	  preexisting	  children	  in	  the	  family.	  The	  two	  groups	  did	  
agree,	  however,	  that	  NMSS	  reflects	  a	  “contemporary	  need	  to	  use	  science	  and	  
technology	  to	  control	  parts	  of	  life	  previously	  left	  to	  chance”	  (Puri	  &	  Nachtigall,	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2010).	  Our	  physicians	  mentioned	  control	  in	  the	  context	  of	  parenting	  norms	  and	  felt	  
it	  was	  natural	  for	  parents	  to	  want	  to	  control	  outcomes,	  but	  that	  people	  and	  science	  
are	  too	  complex	  to	  control.	  This	  sometimes	  led	  to	  the	  concern	  about	  parents’	  
expectations	  of	  a	  “designed”	  child	  and	  whether	  the	  parents	  would	  suffer	  significant	  
disappointment.	  Additionally	  there	  was	  concern	  around	  whether	  the	  child	  would	  be	  
appreciated	  as	  an	  end	  rather	  than	  as	  a	  means	  to	  one,	  especially	  if	  the	  parents’	  
expectations	  were	  not	  met.	  Physicians	  did	  not	  speculate	  about	  the	  likelihood	  of	  
these	  issues,	  but	  some	  incorporated	  awareness	  of	  expectations	  into	  their	  counseling	  
of	  patients.	  	  
	  
BENEFITS	  AND	  HARMS	  
Culture	  and	  the	  Sex	  Ratio	  
Like	  Puri	  and	  Nachtigall’s	  SSTPs,	  some	  of	  our	  physicians	  noted	  that	  the	  
majority	  of	  serious	  NMSS	  requests	  came	  from	  certain	  ethnic	  groups	  and,	  in	  that	  
case,	  were	  almost	  always	  requests	  for	  males	  (2010).	  As	  a	  result,	  REs	  and	  OB/GYNs	  
alike	  were	  highly	  likely	  to	  mention	  the	  unbalanced	  sex	  ratio	  in	  Asia	  and	  list	  the	  
possibility	  of	  sex	  ratio	  skew	  in	  the	  US	  as	  a	  potential	  harm	  of	  NMSS.	  Providers	  in	  our	  
sample	  disagreed	  as	  to	  how	  likely	  it	  was	  that	  a	  skew	  could	  occur	  in	  the	  US.	  They	  
noted	  that	  if	  NMSS	  was	  only	  recommended	  for	  family	  balancing	  then	  the	  result	  
should	  be	  an	  even	  number	  of	  requests	  for	  each	  sex.	  In	  a	  study	  of	  fertility	  clinics	  
across	  America,	  of	  92	  couples	  undergoing	  IVF	  for	  family	  balancing	  between	  2004	  
and	  2006,	  36	  cycles	  were	  for	  females	  and	  56	  for	  males.	  Overall,	  this	  seems	  to	  
indicate	  a	  lack	  of	  preference	  for	  one	  sex	  over	  the	  other.	  However,	  the	  patterns	  in	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gender	  selection	  were	  significantly	  different	  by	  ethnicity.	  Chinese,	  Arab/Muslim,	  
and	  Asian-­‐Indian	  couples	  primarily	  selected	  for	  males,	  while	  other	  ethnicities	  
(Caucasian	  and	  Hispanic)	  preferentially	  selected	  for	  females.	  This	  supports	  the	  idea	  
that	  there	  are	  still	  cultural	  biases	  against	  females	  in	  certain	  populations	  and	  that	  
this	  is	  an	  important	  ethical	  consideration	  in	  the	  regulation	  of	  NMSS.	  (Gleicher	  and	  
Barad,	  2007).	  	  
The	  ASRM	  concludes	  that	  gender	  skew	  and	  population	  limitation	  (through	  
family	  planning)	  are	  too	  speculative	  to	  be	  important	  in	  considering	  guidelines	  and	  
recommendations	  around	  NMSS.	  This	  is	  in	  line	  with	  the	  majority	  of	  predictions	  
made	  by	  participants	  in	  our	  sample,	  but	  fails	  to	  account	  for	  the	  importance	  of	  the	  
issue	  to	  physicians.	  Physicians	  were	  wary	  of	  the	  potential	  for	  a	  future	  skew	  or	  of	  
NMSS’s	  indirect	  implications	  for	  the	  valuing,	  or	  devaluing,	  of	  both	  genders.	  
Otherwise	  said,	  “ongoing	  problems	  with	  the	  status	  of	  women	  in	  the	  United	  States	  
make	  it	  necessary	  to	  take	  account	  of	  concerns	  for	  the	  impact	  of	  sex	  selection	  on	  
goals	  of	  gender	  equality”	  (ASRM).	  	  
	  
DECISION-­MAKING	  	  
Preferences	  for	  Guidelines	  and	  Regulations	  
Several	  physicians	  in	  our	  study	  mentioned	  a	  need	  for	  current	  research	  as	  a	  
means	  to	  create	  NMSS-­‐related	  policy;	  they	  reasoned	  that	  the	  longer	  physicians	  and	  
societies	  waited,	  the	  more	  likely	  they	  were	  to	  run	  into	  more	  complex	  ethical	  
scenarios	  and	  find	  themselves	  without	  guidelines.	  For	  example,	  several	  predicted	  
that	  the	  category	  of	  “medical”	  would	  shift	  to	  include	  traits	  previously	  considered	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“non-­‐medical.”	  Likewise,	  Stern	  et	  al	  conclude	  that	  “laws	  governing	  new	  technology	  
tend	  to	  lag	  so	  far	  behind	  the	  technology	  itself	  that	  they	  are	  often	  in	  danger	  of	  being	  
obsolete	  by	  the	  time	  the	  legislation”	  (2003).	  Ironically,	  more	  than	  a	  decade	  later,	  
this	  study	  has	  reached	  the	  same	  conclusion:	  physicians	  are	  interested	  in	  guidelines	  
because	  of	  the	  ethical	  complexity	  of	  a	  technology	  with	  the	  potential	  to	  affect	  the	  
population	  or	  cause	  significant	  harm.	  Though	  ACOG	  and	  ASRM	  have	  guidelines,	  as	  
described	  earlier,	  they	  come	  to	  different	  conclusions	  and	  are	  ultimately	  
unenforceable.	  
Puri	  and	  Nachtigall	  (2010)	  found	  that	  sex	  selection	  providers	  were	  averse	  to	  
regulation	  of	  sex	  selection,	  seeing	  it	  as	  a	  threat	  to	  patient	  autonomy	  and	  
reproductive	  rights.	  Given	  that	  the	  nature	  of	  their	  work	  involved	  performing	  
elective	  “patient-­‐driven”	  procedures,	  they	  felt	  better	  able	  to	  respect	  patient	  choice.	  	  
Likewise,	  some	  of	  our	  physicians	  preferred	  a	  policy	  in	  which	  they	  would	  still	  retain	  
the	  power	  to	  make	  decisions	  alone	  or,	  more	  often,	  jointly	  with	  the	  patient.	  Others,	  
however,	  felt	  that	  a	  blanket	  ban	  on	  NMSS	  would	  be	  their	  ideal	  policy.	  When	  asked	  to	  
create	  their	  own	  policy,	  most	  participants	  gave	  conflicting	  answers	  (e.g.	  saying	  that	  
a	  professional	  society	  guideline	  was	  ideal	  but	  not	  preferred)	  or	  were	  unable	  to	  
answer.	  	  In	  any	  event,	  the	  ASRM	  states:	  “Until	  a	  more	  clearly	  persuasive	  ethical	  
argument	  emerges,	  or	  there	  is	  stronger	  empirical	  evidence	  that	  most	  choices	  to	  
select	  the	  gender	  of	  offspring	  would	  be	  harmful,	  policies	  to	  prohibit	  or	  condemn	  as	  
unethical	  all	  uses	  of	  non-­‐medically	  indicated	  preconception	  gender	  selection	  are	  not	  
justified.”	  The	  ASRM	  statement	  is	  largely	  consistent	  with	  the	  opinions	  expressed	  by	  
our	  participants.	  Without	  evidence	  of	  a	  significant	  problem	  with	  empirical	  evidence,	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like	  a	  skewed	  sex	  ratio,	  or	  an	  ethical	  argument	  strong	  enough	  to	  trump	  the	  
misgivings	  of	  providers,	  many	  participants	  did	  not	  favor	  complete	  prohibition	  of	  
NMSS.	  The	  ASRM,	  like	  many	  of	  our	  participants,	  is	  unable	  to	  draw	  a	  hard	  line	  on	  
NMSS	  because	  of	  the	  complexities	  and	  nuances	  of	  its	  usage	  and	  implications.	  
	  
The	  Slippery	  Slope	  
	   The	  ASRM	  clearly	  states	  that	  we	  need	  to	  pay	  attention	  to	  ethical	  and	  social	  
concerns	  before	  assisted	  reproductive	  technology	  is	  available	  for	  non-­‐medical	  use.	  
To	  that	  effect,	  three	  physicians	  brought	  up	  the	  “slippery	  slope”	  concern,	  always	  in	  
reference	  to	  the	  perceived	  inevitability	  of	  non-­‐medical	  trait	  selection	  (NMTS).	  The	  
“slippery	  slope”	  assumes	  that	  there	  is	  no	  clear	  line	  between	  what	  is	  appropriate	  for	  
PGD	  and	  what	  is	  not.	  As	  to	  this	  slippery	  slope	  concern,	  the	  ASRM	  acknowledges	  that	  
“[the	  idea	  that]	  offering	  parental	  choices	  of	  sex	  selection	  is	  taking	  a	  major	  step	  
toward	  ‘designing’	  offspring”	  is	  “not	  unreasonable”	  (ASRM).	  Yet,	  they	  continue,	  the	  
slippery	  slope	  argument	  is	  “overdrawn”	  since	  the	  desire	  to	  control	  the	  gender	  of	  
one’s	  child	  is	  “older	  than	  the	  new	  technologies	  that	  make	  this	  possible”	  (ASRM).	  
Essentially,	  the	  ASRM	  seems	  to	  agree	  with	  our	  participants	  that	  NMSS	  could	  lead	  to	  
NMTS,	  but	  that	  cause	  for	  concern	  should	  remain	  low	  for	  now.	  Furthermore,	  as	  
several	  participants	  pointed	  out,	  choosing	  a	  gamete	  donor	  or	  even	  a	  partner	  (sexual	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IMPLICATIONS	  FOR	  PRACTICE	  AND	  CONCLUSIONS	  
Puri	  &	  Nachtigall	  felt	  that	  they	  could	  have	  had	  a	  sampling	  bias,	  having	  
possibly	  recruited	  physicians	  with	  strong	  feelings	  about	  sex	  selection.	  However,	  
having	  asked	  as	  part	  of	  the	  demographics,	  we	  know	  that	  our	  physicians	  were	  fairly	  
evenly	  distributed	  in	  the	  strength	  of	  their	  opinion	  on	  sex	  selection.	  This	  may	  be	  why	  
we	  didn’t	  find	  as	  great	  a	  divide	  between	  the	  two	  specialties	  and	  could	  also	  play	  a	  
part	  in	  why	  our	  physicians	  tended	  to	  report	  conflicting	  values	  and	  paradoxical	  
beliefs,	  an	  amalgamation	  of	  the	  opinions	  of	  Puri	  &	  Nachtigall’s	  two	  groups.	  Puri	  and	  
Nachtigall	  called	  for	  further	  research	  on	  the	  effects	  of	  sex	  selection	  technologies	  in	  
order	  to	  develop	  evidence-­‐based	  professional	  guidelines.	  This	  study,	  like	  theirs,	  has	  
uncovered	  “variety,	  emotional	  intensity,	  and	  nuanced	  thoughtfulness	  of	  the	  opinions	  
and	  concerns”	  elicited	  around	  NMSS	  and	  NMTS.	  	  	  
To	  reiterate	  an	  important	  earlier	  point,	  providers	  in	  the	  Puri	  and	  Nachtigall	  
study	  indicated	  that	  even	  if	  they	  have	  only	  dealt	  with	  a	  small	  number	  of	  sex	  
selection	  cases	  in	  their	  career,	  their	  emotional	  impact	  made	  them	  memorable	  in	  
physicians’	  professional	  lives.	  This	  was	  part	  of	  the	  rationale	  for	  the	  current	  study	  
and	  for	  the	  selection	  of	  the	  Moral	  Experience	  framework.	  The	  experiences	  described	  
by	  our	  physicians	  bore	  this	  out.	  Major	  themes	  revealed	  across	  the	  interviews	  were	  
those	  of	  ambivalence	  and	  conflict,	  and	  the	  struggle	  to	  “draw	  a	  line,”	  whether	  it	  was	  
between	  personal	  and	  professional	  attitudes,	  between	  family	  balancing	  and	  
selection	  of	  the	  first	  child,	  or	  between	  medical	  and	  non-­‐medical	  traits,	  among	  many	  
others.	  Physicians	  communicated	  that	  this	  uncertainty	  is	  distressing	  and	  often	  the	  
cause	  of	  ethical	  dilemmas	  in	  everyday	  practice.	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In	  summary,	  the	  main	  findings	  of	  this	  study	  are	  as	  follows.	  The	  majority	  of	  
our	  physicians	  were	  personally,	  if	  not	  professionally,	  opposed	  to	  NMSS	  and	  NMTS.	  
The	  two	  primary	  harms	  of	  NMSS,	  as	  expressed	  by	  the	  physicians,	  were	  sex	  ratio	  
skews	  and	  sexism.	  Autonomy	  played	  the	  most	  important	  part	  in	  determining	  a	  
physician’s	  behavior	  around	  NMSS.	  Belief	  in	  patient	  autonomy	  was	  also	  the	  value	  
most	  in	  conflict	  with	  other	  values,	  though	  it	  could	  be	  occasionally	  trumped	  by	  
justice	  or	  “do	  no	  harm.”	  Some	  physicians	  were	  concerned	  that	  parents	  exert	  too	  
much	  control	  over	  their	  reproduction	  and	  this	  may	  result	  in	  disappointment	  of	  
expectations	  as	  well	  as	  a	  failure	  to	  value	  the	  differences	  among	  people.	  Some	  
physicians	  would	  prefer	  a	  blanket	  ban	  on	  NMSS,	  while	  others	  feel	  that	  professional	  
societies	  should	  be	  responsible	  for	  creating	  guidelines	  or	  regulations	  that	  are	  not	  so	  
restrictive	  that	  the	  provider	  cannot	  go	  against	  them	  if	  their	  better	  judgment	  
demands.	  	  
There	  have	  been	  many	  calls	  for	  additional	  research	  into	  the	  ethics	  of	  NMSS	  so	  
as	  to	  create	  useful	  professional	  guidelines	  that	  are	  not	  too	  restrictive	  of	  providers	  or	  
their	  patients,	  but	  also	  provide	  guidance	  as	  technology	  evolves	  and	  ethical	  dilemmas	  
arise.	  This	  study	  provides	  evidence	  for	  the	  nuanced	  attitudes	  that	  physicians	  have	  
toward	  NMSS	  as	  well	  as	  the	  values	  that	  shape	  these	  attitudes.	  What	  has	  emerged	  is	  
the	  importance	  of	  patient	  autonomy,	  but	  also	  the	  need	  for	  permission	  to	  allow	  
justice	  or	  “do	  no	  harm”	  to	  weigh	  as	  heavily	  in	  internal	  debates	  as	  autonomy.	  Since	  
physicians	  prefer	  to	  make	  joint	  decisions	  with	  their	  patients,	  we	  can	  imagine	  that	  
allowing	  them	  the	  time	  to	  counsel	  their	  patients	  about	  expectations	  and	  discuss	  
society-­‐level	  implications	  will	  become	  increasingly	  important	  as	  the	  technology	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becomes	  easier	  to	  access.	  Lastly,	  our	  data	  suggest	  that	  it	  is	  important	  that	  
regulations	  be	  flexible	  enough	  to	  allow	  technology	  to	  evolve,	  but	  also	  that	  they	  set	  
boundaries	  to	  diminish	  the	  chances	  of	  ethical	  dilemmas.	  	  
	  
DEMOGRAPHICS	  
No	  definitive	  statements	  can	  be	  made	  about	  the	  effects	  of	  demographic	  
variables	  on	  responses	  and	  patterns	  because	  of	  the	  low	  number	  of	  respondents	  and	  
lack	  of	  thematic	  saturation.	  That	  being	  said,	  certain	  questions	  were	  added	  to	  the	  
demographics	  questionnaire	  based	  on	  previous	  studies	  with	  evidence	  suggestive	  of	  
differences	  among	  certain	  groups.	  Parenting	  status	  was	  of	  interest	  because	  
respondents	  (OBGYNs)	  in	  the	  Caldas	  et	  al	  study	  (2010)	  were	  more	  likely	  to	  approve	  
of	  PGD	  if	  they	  had	  children	  themselves.	  In	  our	  study,	  12	  of	  14	  physicians	  were	  
parents	  so	  they	  could	  not	  be	  compared	  to	  the	  group	  of	  2	  non-­‐parents.	  However,	  as	  
being	  a	  parent	  was	  a	  value	  cited	  by	  many	  of	  these	  physicians,	  it	  is	  not	  unlikely	  that	  
greater	  numbers	  of	  participants	  could	  reveal	  a	  difference	  in	  trends	  between	  parents	  
and	  non-­‐parents.	  	  
Sex	  was	  of	  interest	  because	  male	  physicians	  were	  significantly	  more	  likely	  to	  
approve	  of	  PGD	  than	  female	  physicians	  in	  the	  Caldas	  et	  al	  study	  (2010).	  Males	  and	  
females	  in	  this	  study	  did	  not	  apparently	  differ	  on	  how	  likely	  they	  were	  to	  approve	  of	  
NMSS	  nor	  did	  they	  appear	  to	  differ	  in	  their	  attitudes	  or	  level	  of	  conflict.	  Additionally,	  
specialty	  and	  type	  of	  workplace	  are	  important	  given	  that	  respondents	  practicing	  in	  
ART	  settings	  were	  more	  agreeable	  to	  PGD	  (Caldas	  et	  al,	  2010).	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It	  is	  worth	  noting	  that	  there	  do	  not	  appear	  to	  be	  differences	  in	  the	  attitudes	  
of	  OB/GYNs	  and	  Res	  thus	  far.	  Their	  experiences	  differ	  as	  a	  function	  of	  their	  different	  
specialties,	  but	  REs	  list	  approximately	  the	  same	  number	  of	  benefits	  and	  harms	  as	  
OB/GYNs.	  It	  may	  be	  that	  REs	  who	  work	  in	  clinics	  that	  offer	  NMSS	  are	  more	  neutral	  
around	  family	  balancing	  than	  other	  REs	  or	  OB/GYNs,	  but	  there	  is	  not	  yet	  enough	  
data	  to	  explore	  whether	  the	  specialties	  feel	  similar	  levels	  of	  conflict.	  There	  seemed	  
to	  be	  an	  equal	  number	  of	  physicians	  responding	  to	  hypothetical	  scenarios	  and	  
referring	  to	  lived	  experiences.	  This	  didn’t	  seem	  to	  vary	  systematically	  with	  any	  
attributes,	  nor	  did	  it	  seem	  to	  affect	  attitudes.	  Lastly,	  strength	  of	  opinion	  about	  NMSS	  
only	  seemed	  relevant	  to	  number	  of	  harms	  and	  benefits	  listed,	  with	  “not	  strong”	  
participants	  listing	  fewer	  of	  each,	  though	  they	  didn’t	  differ	  in	  content.	  
	  
LIMITATIONS	  AND	  FUTURE	  DIRECTIONS	  
The	  most	  important	  limitation	  of	  this	  study	  is	  the	  low	  number	  of	  participants	  
and	  therefore	  our	  inability	  to	  reach	  thematic	  saturation.	  The	  number	  of	  participants	  
also	  made	  it	  uninformative	  to	  compare	  sub-­‐groups	  on	  demographic	  characteristics	  
or	  other	  attributes.	  The	  study	  was	  not	  intended	  to	  be	  generalizable	  to	  all	  OB/GYNs	  
and	  REs;	  future	  quantitative	  studies,	  based	  on	  the	  initial	  qualitative	  work,	  would	  be	  
able	  to	  recruit	  enough	  physicians	  to	  have	  generalizable	  results.	  Future	  quantitative	  
work	  could	  focus	  on	  a	  variety	  of	  relevant	  topics	  including	  mediators	  of	  decision-­‐
making;	  moderators	  of	  conflict	  between	  personal	  and	  professional	  attitudes;	  the	  
demographic	  factors	  that	  predict	  a	  physician’s	  values,	  attitudes,	  or	  behaviors;	  a	  
forced-­‐choice	  design	  to	  better	  understand	  which	  values	  commonly	  outweigh	  other	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values;	  and	  others.	  Another	  potential	  problem	  is	  the	  use	  of	  one	  interviewer	  for	  all	  
interviews.	  Although	  the	  interview	  guide	  was	  designed	  with	  the	  input	  of	  several	  
people,	  and	  worded	  to	  be	  as	  neutral	  as	  possible,	  it’s	  possible	  that	  any	  biases	  of	  the	  
interviewer	  had	  some	  effect	  on	  the	  direction	  of	  the	  interview.	  	  
Though	  we	  chose	  the	  two	  specialties	  of	  medicine	  carefully,	  we	  did	  exclude	  
other	  stakeholders	  and	  potential	  gatekeepers.	  Future	  studies	  could	  try	  to	  ascertain	  
why	  it	  is	  that	  certain	  providers	  identify	  as	  gatekeepers	  and	  others	  don’t.	  
Furthermore,	  if	  genetic	  counselors	  have	  the	  potential	  to	  be	  gatekeepers	  or	  at	  least	  
be	  involved	  in	  PGD,	  it	  would	  be	  important	  to	  assess	  their	  values	  and	  current	  
practices.	  Through	  her	  conversations	  with	  genetic	  counselors	  about	  various	  uses	  of	  
PGD,	  Everton	  (2014)	  found	  that	  71%	  agreed	  that	  PGD	  should	  not	  be	  used	  for	  sex	  
selection.	  Because	  of	  the	  absence	  of	  genetic	  counselors	  in	  reproductive	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APPENDICES	  
	  
APPENDIX	  A	  :	  RECRUITMENT	  LETTER	  	  
	  
Dear	  Dr.	  	  
	   I	  am	  a	  graduate	  student	  working	  with	  investigators	  from	  the	  Johns	  Hopkins	  
University	  Bloomberg	  School	  of	  Public	  Health	  and	  National	  Human	  Genome	  
Research	  Institute	  as	  part	  of	  my	  Master’s	  thesis	  for	  the	  Genetic	  Counseling	  Training	  
Program.	  We	  are	  interested	  in	  physicians’	  attitudes	  toward	  and	  experiences	  of	  non-­‐
medical	  sex	  selection	  (NMSS).	  	  The	  purpose	  of	  this	  research	  is	  to	  learn	  more	  about	  
physician’s	  experiences	  with	  and	  attitudes	  toward	  prenatal	  genetic	  diagnosis	  (PGD)	  
for	  non-­‐medical	  sex	  selection.	  You	  are	  eligible	  to	  complete	  this	  survey	  if	  you	  are	  
currently	  providing	  care	  to	  patients.	  
	  
	   The	  study	  will	  involve	  conducting	  one-­‐time	  telephone	  interviews	  with	  a	  
sample	  of	  physicians	  (OBGYNs	  and	  reproductive	  endocrinologists).	  	  Although	  the	  
length	  of	  time	  will	  vary	  depending	  on	  participants’	  responses,	  we	  expect	  that	  each	  
interview	  will	  take	  about	  30	  minutes.	  If	  you	  are	  not	  interested	  in	  participating	  in	  a	  
telephone	  interview,	  or	  in	  learning	  more	  about	  the	  study,	  please	  respond	  to	  this	  
letter	  using	  the	  attached	  postage-­‐paid	  envelope.	  If	  we	  don’t	  receive	  your	  request	  for	  
no	  further	  contact,	  we	  will	  contact	  you	  by	  telephone	  in	  one	  week	  to	  ask	  about	  your	  
interest	  in	  joining	  this	  study.	  	  
	  
The	  conceptual	  framework	  of	  this	  study	  is	  modeled	  on	  Hunt	  and	  Carnevale’s	  
Moral	  Experience	  framework.	  The	  moral	  experience	  framework	  encompasses	  a	  
person’s	  sense	  that	  the	  values	  important	  to	  them	  are	  being	  realized	  or	  thwarted	  in	  
everyday	  life.	  As	  such,	  this	  is	  an	  opportunity	  to	  reflect	  on	  ethical	  issues	  surrounding	  
the	  use	  of	  PGD	  for	  NMSS.	  We	  are	  interested	  in	  learning	  whether	  there	  are	  conflicts	  
that	  you	  feel	  around	  this	  topic.	  We	  are	  interested	  in	  your	  personal	  opinion,	  which	  
we	  realize	  may	  or	  may	  not	  reflect	  the	  policy	  of	  the	  institution	  with	  which	  you	  are	  
affiliated.	  	  
	  
	  The	  potential	  risks	  from	  completion	  of	  this	  survey	  may	  be	  psychological	  
distress	  from	  being	  reminded	  of	  difficult	  patient	  care	  experiences.	  You	  will	  be	  free	  
to	  stop	  the	  interview	  at	  any	  time.	  If	  you	  decide	  to	  complete	  the	  interview,	  we	  will	  
take	  several	  steps	  to	  protect	  your	  confidentiality.	  Data	  from	  this	  study	  will	  be	  
identified	  with	  a	  code	  number	  and	  not	  your	  name.	  	  The	  code	  number	  allows	  us	  to	  
keep	  track	  of	  who	  has	  not	  responded	  so	  we	  can	  send	  follow-­‐up	  materials.	  	  The	  link	  
between	  participant	  names	  and	  code	  numbers	  will	  be	  safeguarded	  and	  destroyed	  
when	  the	  interviews	  are	  completed.	  	  Your	  name	  will	  never	  be	  used	  when	  reporting	  
any	  of	  the	  results.	  	  Only	  summary	  aggregate	  data	  will	  be	  reported.	  
	  
	  
Thank	  you	  for	  your	  consideration.	  






Nina	  Harkavy,	  B.A.	  
Graduate	  Student,	  Genetic	  Counseling	  Training	  Program	  
Johns	  Hopkins	  University/NHGRI	  Bethesda,	  MD	  
	   nina.harkavy@nih.gov	  
	   (914)-­‐299-­‐9226	  
	  
Lori	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Assistant	  Professor,	  Department	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School	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Public	  Health	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  Hopkins	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Associate	  Investigator,	  Social	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  Research	  Branch,	  NHGRI	  Bethesda,	  MD	  
Adjunct	  Associate	  Professor,	  Department	  of	  Health,	  Behavior	  &	  Society,	  Johns	  
Hopkins	  School	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  Public	  Health	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APPENDIX	  	  B:	  CONSENT	  FORM	  
	  
Protocol	  Title:	  	  Physicians’	  Experiences	  with	  and	  Attitudes	  toward	  Non-­‐Medical	  Sex	  
Selection	  through	  Preimplantation	  Genetic	  Diagnosis	  
	  
Protocol	  No.:	  T-­‐HG-­‐0107	  
	  
Sponsor:	  	  	   National	  Human	  Genome	  Research	  Institute	  (NHGRI)	  
	  
Principal	  Investigator:	   Barbara	  B.	  Biesecker,	  MS,	  CGC	  
Associate	  Investigator,	  Social	  &	  Behavioral	  Research	  




You	  are	  invited	  to	  participate	  in	  a	  study	  conducted	  by	  researchers	  at	  the	  National	  
Institutes	  of	  Health	  and	  the	  Johns	  Hopkins	  University.	  
	  
Why	  is	  this	  study	  being	  done?	  
To	  learn	  more	  about	  how	  physicians	  experience,	  understand,	  and	  possibly	  struggle	  
with	  non-­‐medical	  sex	  selection.	  	  We	  are	  interested	  in	  hearing	  from	  physicians	  about	  
the	  individual-­‐	  and	  society-­‐level	  ethical	  implications	  of	  NMSS,	  if	  any,	  as	  well	  as	  their	  
role	  in	  NMSS	  decision-­‐making,	  and	  their	  opinions	  as	  to	  the	  appropriateness	  of	  other	  
hypothetical	  non-­‐medical	  traits.	  
	  
We	  plan	  to	  enroll	  OBGYNs	  and	  reproductive	  endocrinologists	  who	  currently	  see	  
patients.	  	  
	  
Who	  can	  take	  part	  in	  this	  study?	  
You	  must	  be	  18	  years	  of	  age	  or	  older	  and	  must	  be	  an	  English-­‐speaking	  OBGYN	  or	  	  
reproductive	  endocrinologist	  currently	  practicing	  in	  the	  US.	  
	  
What	  is	  involved	  in	  this	  study?	  
There	  is	  one	  interview	  that	  takes	  approximately	  30	  minutes	  to	  complete.	  It	  will	  be	  
conducted	  with	  one	  of	  the	  investigators	  (NH)	  over	  the	  phone	  and	  recorded	  to	  be	  
transcribed	  later.	  	  
	  
What	  are	  the	  risks	  of	  the	  study?	  
There	  are	  no	  known	  risks	  of	  taking	  part	  in	  this	  study.	  	  If	  taking	  the	  interview	  makes	  
you	  feel	  uncomfortable,	  you	  can	  stop	  taking	  the	  survey	  at	  any	  time.	  If	  it	  causes	  you	  
discomfort,	  you	  can	  contact	  the	  researchers	  (below)	  and	  they	  will	  help	  direct	  you	  to	  
appropriate	  resources.	  	  
	  
Are	  there	  benefits	  to	  taking	  part	  in	  the	  study?	  
You	  will	  not	  personally	  benefit	  from	  taking	  part	  in	  this	  study.	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Do	  I	  have	  to	  participate?	  
No,	  you	  do	  not	  have	  to	  take	  part	  in	  this	  study	  if	  you	  do	  not	  want	  to.	  	  If	  you	  begin	  the	  
interview,	  you	  can	  choose	  to	  skip	  any	  question	  that	  you	  don’t	  want	  to	  answer.	  	  You	  
can	  also	  stop	  the	  interview	  at	  any	  time.	  	  	  
	  
Will	  I	  be	  compensated	  for	  my	  participation?	  
You	  will	  not	  receive	  financial	  compensation,	  but	  the	  researchers	  are	  offering	  to	  
share	  the	  results	  of	  the	  study	  with	  you	  if	  you	  would	  like.	  
	  
How	  will	  your	  privacy	  be	  protected?	  	  
We	  will	  take	  several	  steps	  to	  minimize	  the	  likelihood	  of	  a	  breach	  of	  confidentiality.	  
Your	  name	  will	  not	  be	  linked	  to	  the	  transcribed	  interview;	  only	  your	  demographic	  
information	  will	  be	  linked	  to	  your	  responses.	  Only	  summary	  aggregate	  data	  will	  be	  
reported.	  
	  
Your	  signature	  is	  not	  required.	  You	  will	  be	  sent	  this	  consent	  form	  prior	  to	  your	  
interview.	  On	  the	  day	  of	  your	  interview,	  the	  interviewer	  (NH)	  will	  read	  the	  consent	  
aloud.	  If	  you	  agree	  to	  participate,	  you	  will	  give	  verbal	  consent	  that	  you	  understand	  
the	  consent	  form.	  
.	  
Thank	  you	  for	  your	  interest	  and	  time!	  	  Please	  print	  a	  copy	  of	  this	  consent	  form	  so	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APPENDIX	  C:	  INTERVIEW	  GUIDE	  
The	  interview	  will	  not	  necessarily	  follow	  this	  guide	  directly.	  	  Sections	  may	  be	  
discussed	  in	  different	  orders,	  depending	  on	  the	  direction	  in	  which	  the	  interviewee	  
takes	  the	  conversation.	  	  However,	  every	  effort	  will	  be	  made	  to	  cover	  each	  section	  at	  
some	  point	  during	  the	  interview.	  	  	  
	  
I.	  	  	  
 Have	  you	  had	  a	  patient	  ask	  about	  or	  request	  non-­‐medical	  sex	  selection,	  either	  
for	  family	  balancing	  or	  a	  first	  child?	  What	  did	  you	  think	  about	  this	  request?	  
How	  did	  you	  feel	  about	  this	  request?	  How	  did	  you	  respond?	  
o (For	  all	  physicians,	  read	  the	  following	  vignettes	  and	  prompt	  the	  same	  
follow-­‐up	  questions	  for	  each:	  A	  couple	  comes	  into	  your	  office	  asking	  
about/for	  family	  balancing	  services	  because	  they	  have	  two	  children	  of	  
the	  same	  sex	  and	  would	  like	  to	  ensure	  that	  their	  next	  child	  is	  the	  other	  
sex.	  Now	  consider	  that	  the	  couple	  is	  requesting	  non-­‐medical	  sex	  
selection	  to	  determine	  the	  sex	  of	  their	  first	  child.	  Imagine	  the	  “usual”	  
type	  of	  couple	  that	  can	  afford	  to	  access	  NMSS	  via	  PGD	  (e.g.	  Caucasian,	  
higher	  socioeconomic	  status)	  rather	  than	  your	  (the	  physician’s)	  usual	  
type	  of	  patient	  because	  some	  of	  you	  work	  with	  populations	  who	  
rarely	  or	  never	  have	  access	  to	  PGD	  for	  economic	  or	  cultural	  reasons.	  
 Have	  you	  ever	  brought	  up	  NMSS	  with	  a	  patient?	  Why	  or	  why	  not?	  Can	  you	  
imagine	  a	  context	  in	  which	  you	  would	  want	  to	  bring	  it	  up?	  What	  would	  that	  
be?	  
II.	  	  
 What	  do	  you	  see	  as	  possible	  implications,	  both	  positive	  and	  negative,	  of	  
NMSS?	  What	  do	  you	  see	  as	  possible	  benefits	  and/or	  harms	  to	  a	  couple?	  To	  
the	  provider?	  To	  the	  practice?	  To	  society?	  
 Do	  you	  talk	  to	  your	  patients	  about	  any	  of	  these	  implications	  of	  NMSS?	  If	  so,	  
which	  ones	  and	  how?	  If	  not,	  why	  not?	  Can	  you	  imagine	  talking	  about	  this	  
with	  patients?	  
 When	  people	  have	  to	  think	  through	  difficult	  issues,	  they	  often	  consider	  what	  
values	  or	  beliefs	  are	  important	  to	  them.	  What	  things	  that	  you	  value,	  things	  
that	  are	  important	  to	  you,	  and	  beliefs	  that	  you	  hold,	  influence	  how	  you	  think	  
and	  feel	  about	  NMSS?	  (Prompt:	  These	  may	  include	  professional	  beliefs	  (what	  
it	  means	  to	  be	  a	  doctor),	  religious	  beliefs,	  moral	  beliefs,	  political	  views,	  or	  
other	  values	  that	  are	  important	  to	  you.)	  Can	  you	  talk	  through	  an	  example	  of	  
how	  each	  value	  has	  affected	  your	  thinking	  or	  practices	  about	  NMSS?	  
III.	  	  	  
 Where	  you	  work,	  who	  makes	  decisions	  about	  recommending	  and/or	  offering	  
NMSS	  to	  patients?	  How	  do	  you	  feel	  that	  is	  working	  in	  your	  practice?	  
 Do	  you	  see	  yourself/physicians	  generally	  in	  a	  gate-­‐keeping	  role	  for	  NMSS?	  In	  
what	  ways?	  	  
 Who	  do	  you	  think	  should	  have	  the	  power	  to	  make	  decisions	  about	  NMSS?	  
(Prompt:	  The	  individual	  physician?	  The	  couple?	  The	  medical	  center?	  A	  
professional	  society?	  A	  combination?)	  Why?	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 If	  you	  could	  create	  policy	  around	  NMSS,	  what	  would	  it	  be	  and	  why?	  (First	  for	  
your	  institution	  then,	  more	  broadly,	  do	  you	  think	  there	  should	  be	  a	  national	  
policy?	  What	  would	  that	  look	  like?	  How	  specific	  would	  you	  want	  the	  
guidance	  from	  a	  national	  body	  to	  be?	  What	  should	  it	  include?)	  
IV.	  	  	  
 What	  non-­‐medical	  traits	  are	  appropriate	  or	  inappropriate	  for	  PGD?	  Why	  are	  
or	  aren’t	  they	  appropriate?	  Is	  NMSS	  different	  from	  selection	  of	  other	  non-­‐
medical	  traits?	  (Examples	  if	  needed	  include	  physical	  traits,	  cognitive	  abilities,	  
talents/skills,	  etc.)	  	  
 How	  do	  you	  decide	  where	  you	  (personally,	  professionally)	  draw	  the	  line	  
between	  appropriate	  and	  inappropriate	  traits?	  	  
 Have	  patients	  asked	  about	  the	  possibility	  of	  selecting	  for	  or	  against	  other	  
non-­‐medical	  traits?	  (Prompt	  physicians’	  feelings	  and	  emotional	  experience	  
beyond	  the	  yes/no	  answer.)	  
 What	  non-­‐medical	  traits	  do	  you	  foresee	  your	  patients	  requesting?	  How	  
would	  you	  respond	  to	  these	  requests?	  	  
 Are	  there	  any	  other	  thoughts	  that	  you	  want	  to	  share	  on	  this	  topic	  broadly	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APPENDIX	  E:	  DEMOGRAPHICS	  QUESTIONNAIRE	  	  
	  
Now	  we’d	  like	  to	  ask	  you	  a	  brief	  series	  of	  demographic	  questions.	  This	  information	  
helps	  us	  to	  ensure	  that	  we	  recruit	  a	  diverse	  sample	  of	  physicians.	  Only	  summary	  
aggregate	  data	  will	  be	  reported.	  
	  
Are	  you	  currently	  seeing	  patients?	  
	  
What	  is	  your	  age?	  
	  





What	  is	  your	  medical	  specialty?	  
_	  OB/GYN	  
_	  Reproductive	  Endocrinology	  
	  
In	  what	  part	  of	  the	  country	  do	  you	  work?	  	  
_	  Northeast	  (CT,	  ME,	  MA,	  NH,	  RI,	  VT,	  NJ,	  NY,	  PA)	  	  
_	  Midwest	  (IL,	  IN,	  MI,	  OH,	  WI,	  IA,	  KS,	  MN,	  MO,	  NE,	  ND,	  SD)	  
_	  South	  (DE,	  FL,	  GA,	  MD,	  NC,	  SC,	  VA,	  Washington	  D.C.,	  WV,	  AR,	  LA,	  OK,	  TX)	  
_	  West	  (AZ,	  CO,	  ID,	  MT,	  NV,	  NM,	  UT,	  WY,	  AK,	  CA,	  HI,	  OR,	  WA)	  
	  
For	  how	  many	  years	  have	  you	  been	  in	  practice?	  
	  




_	  Private	  Practice	  
_	  Other	  
	  
The	  following	  questions	  will	  help	  us	  characterize	  your	  typical	  patient	  population:	  
Roughly	  what	  percentage	  of	  your	  patients	  are	  Caucasian?	  Hispanic?	  African-­‐
American?	  Asian?	  	  
Roughly	  what	  percentage	  of	  your	  patients	  are	  on	  public	  assistance?	  
Roughly	  what	  percentage	  of	  your	  patients	  have	  a	  household	  income	  over	  200,000	  
annually?	  
Roughly	  what	  percentage	  of	  your	  patients	  are	  under	  25?	  Between	  25	  and	  35?	  Over	  
35?	  
	  
Are	  you	  yourself	  a	  parent?	  	  
_	  Yes	  
_	  No	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How	  strong	  are	  your	  feelings	  toward	  non-­‐medical	  sex	  selection?	  Please	  choose	  one:	  
not	  strong,	  somewhat	  strong,	  strong,	  or	  very	  strong.	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APPENDIX	  F:	  OPT-­OUT	  LETTER	  
	  
I,	  (please	  print	  your	  name)	  __________________________________	  ,	  decline	  to	  participate	  in	  
the	  study	  Physicians’	  Experiences	  with	  and	  Attitudes	  toward	  Non-­‐Medical	  Sex	  
Selection	  through	  Preimplantation	  Genetic	  Diagnosis.	  By	  sending	  this	  letter	  back	  to	  
the	  researchers,	  I	  am	  declining	  further	  contact	  with	  them	  and	  understand	  that	  I	  will	  
not	  receive	  any	  additional	  follow-­‐up	  phone	  calls	  about	  this	  study.	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APPENDIX	  G:	  CODEBOOK	  
As	  of	  January	  2015	  
	  
100	  Against	  NMSS	  
	   101	  Reasons	  against	  
	   	  
200	  Benefits	  of	  NMSS	  
	   201	  Individual	  
	   202	  Couple/Family	  
	   203	  Provider	  
	   204	  Societal	   	  
	   205	  None	  
	  
300	  Conflicting	  Values	  related	  to	  NMSS	  
Use	  anytime	  the	  participant	  talks	  about	  how	  their	  personal	  values	  might	  be	  in	  
conflict.	  
	  
	   301	  Trump	  	  
When	  a	  values	  conflict	  is	  resolved	  because	  the	  physician	  allows	  one	  value	  to	  
“trump”	  another.	  For	  example,	  a	  physician	  resolves	  their	  conflict	  around	  
discouraging	  NMSS	  by	  allowing	  their	  value	  of	  	  nonmaleficence	  (“do	  no	  
harm”)	  to	  trump	  their	  value	  of	  patient	  autonomy.	  
	  
302	  Ethical	  Dilemma	  
This	  is	  used	  when	  a	  physician	  explicitly	  identifies	  something	  as	  a	  “moral”	  or	  
“ethical”	  dilemma.	  
	  
400	  Decision-­‐Making	  	  
Who	  makes	  decisions/should	  make	  decisions	  about	  NMSS,	  which	  may	  be	  double	  
coded	  with	  a	  time	  orientation	  such	  as	  currently	  it	  is	  up	  to	  the	  physician	  (402	  and	  
406)	  but	  I	  prefer	  it	  were	  up	  to	  ACOG	  (404	  and	  408).	  
	   	  
401	  Patient	  only	  
	   402	  Physician(s)	  only	  
	   403	  Joint	  (Patient	  and	  Physician)	  
	   404	  Professional	  Society	  or	  Government/Legislature	  
405	  Uncertain-­‐	  use	  for	  uncertainty	  or	  ambivalence	  about	  who	  should	  make	  
decisions	  or	  what	  policies	  should	  be.	  
406	  Current	  –	  use	  for	  discussions	  about	  current	  practices	  
407	  Future	  –	  use	  for	  discussions	  about	  what	  should/will	  happen	  in	  the	  future	  
408	  Preferred-­‐	  use	  for	  discussions	  about	  who	  the	  participant	  thinks	  should	  
make	  decisions	  or	  how	  they	  should	  be	  made	  
409	  Gate-­‐Keeping-­‐	  use	  whenever	  participant	  talks	  about	  his/her	  role	  or	  the	  
profession’s	  role	  as	  gatekeeper;	  this	  includes	  discussions	  about	  why	  
someone	  is	  not	  a	  gatekeeper.	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500	  Ethnicity	  and	  Culture	  
Use	  for	  any	  discussion	  about	  ethnicity	  or	  culture.	  
	  
600	  Expectations	  	  
This	  does	  not	  refer	  to	  the	  participant’s	  expectations	  but	  rather	  when	  the	  participant	  
talks	  about	  the	  expectations	  of	  their	  patients	  such	  as	  expectations	  of	  a	  child	  based	  
on	  gender	  roles	  or	  the	  expectation	  of	  perfection.	  
	  
	  
700	  For	  NMSS	  
	   701	  Reasons	  for	  
	  
800	  Gender	  –	  use	  to	  code	  for	  any	  discussion	  about	  gender	  
	   801	  Gender	  Roles	  
	   802	  Sexism	  
	  
900	  Harms	  of	  NMSS	  
	   901	  Individual	  
	   902	  Couple/Family	  
	   903	  Provider	  
	   904	  Societal	  
904.1	  Sex	  Ratio-­‐	  Use	  any	  time	  someone	  mentions	  the	  possibility	  of	  a	  
sex	  ratio	  skew	  or	  refers	  to	  the	  sex	  ratio	  in	  other	  countries,	  even	  if	  they	  
deem	  it	  unlikely.	   	  
	   905	  None	  
	  
1000	  Hypothetical	  
If	  the	  physician	  is	  discussing	  hypothetical	  cases,	  rather	  than	  lived	  experiences.	  
Double	  code	  with	  other	  codes	  as	  appropriate.	  
1001	  Family	  Balancing	  –	  use	  for	  discussions	  based	  on	  the	  hypothetical	  case	  
related	  to	  a	  second/third/etc	  child	  
1002	  First	  Child	  –	  use	  for	  discussions	  based	  on	  the	  hypothetical	  case	  related	  
to	  a	  first	  child	  
	  
1100	  Non-­‐Hypothetical	  
If	  the	  physician	  is	  referring	  to	  his/her	  experience	  with	  actual	  cases,	  though	  not	  
necessarily	  to	  one	  case	  in	  particular.	  	  Double	  code	  with	  other	  codes	  as	  appropriate	  
1101	  Family	  Balancing	  –	  use	  for	  discussions	  of	  actual	  cases	  with	  requests	  for	  
family	  balancing.	  
1102	  First	  Child	  –	  use	  for	  discussions	  of	  actual	  	  cases	  with	  requests	  for	  NMSS	  
for	  a	  first	  child.	  
	  
1200	  Nature	  
Any	  reference	  to	  nature	  or	  what	  is	  natural	  including	  evolution	  and	  mate	  selection.	  
This	  can	  include	  references	  to	  God	  if	  appropriate	  e.g.	  It’s	  unnatural	  to	  play	  God.	  
	   1201	  Random	  or	  Chance	  
	   80	  
	   1202	  Non-­‐Random	  or	  Predetermined	  
	   1203	  Predetermined	  Randomness	  	  
When	  there	  are	  conflicting	  ideas	  in	  a	  single	  thought.	  For	  example,	  saying	  that	  
a	  goal	  of	  evolution	  is	  randomness	  or	  that	  gender	  needs	  to	  be	  random	  to	  end	  
up	  with	  the	  child	  one	  is	  supposed	  to	  have.	  Basically,	  when	  you	  would	  double-­‐
code	  for	  the	  previous	  two	  codes	  in	  one	  thought.	  
	  
1300	  Other	  Non-­‐Medical	  Traits	  
	   1301	  Against	  NMT	  Selection	  (with	  or	  without	  reasons)	  
	   1302	  For	  NMT	  Selection	  (with	  or	  without	  reasons)	  
	   1303	  Comparison	  to	  Sperm	  or	  Egg	  Donation	  
	   1304	  Predictions	  about	  what	  will	  happen	  with	  this	  in	  the	  future	  
	   	   1304.1	  “Slippery	  Slope”	  
	   	   1304.2	  “Eugenics”	  
	   	   1304.3	  Specific	  Traits	  i.e.	  Blue	  Eyes	  
	   1305	  Compared	  to	  NMSS	  
	  
1400	  Personal	  
Whenever	  the	  physician	  is	  referring	  to	  their	  personal	  feelings,	  ideas,	  thoughts,	  etc.	  
Often	  this	  is	  in	  contrast	  to	  Professional.	  Usually	  the	  quote	  includes	  “Personally”	  or	  
“My	  Personal.”	  Should	  be	  double-­‐coded	  with	  other	  codes.	  
	  
1500	  Professional	  
Whenever	  the	  physician	  is	  referring	  to	  their	  professional	  actions	  or	  the	  policies	  of	  
their	  workplace.	  This	  is	  often	  used	  in	  contrast	  to	  Personal.	  Should	  be	  double-­‐coded	  
with	  other	  codes.	  
	  
1600	  Larger	  Issue	  
This	  code	  may	  be	  used	  when	  a	  participant	  is	  talking	  about	  being	  for,	  being	  against,	  
or	  being	  conflicted	  about	  NMSS.	  	  This	  applies	  when	  the	  participant	  talks	  about	  how	  
NMSS	  is	  being	  used/could	  be	  used/shouldn’t	  be	  used	  as	  a	  solution	  to	  a	  larger	  
societal	  problem	  (eg,	  selecting	  for	  a	  boy	  because	  girls	  are	  poorly	  treated).	  The	  
physician	  may	  acknowledge	  that	  choosing	  a	  gender	  is	  the	  result	  of	  a	  greater	  societal	  
problem	  and	  will	  not	  help	  change	  or	  rectify	  that	  problem,	  except	  possibly	  on	  an	  
individual	  level,	  and	  may	  even	  exacerbate	  that	  problem	  on	  a	  societal-­‐level.	  
	  
1700	  Values	  
One's	  judgment	  of	  what	  is	  important	  in	  life.	  	  
1701	  Medical	  Ethics	  Principles	  (Beneficence,	  Do	  No	  Harm,	  Justice,	  
Autonomy).	  	  
1701.1	  Justice.	  This	  may	  include	  themes	  around	  Frivolous	  or	  
Unnecessary,	  Access,	  Allocation	  of	  Resources,	  or	  Financial	  Burden.	  
1701.2	  Non-­‐Maleficence	  (Do	  No	  Harm).	  This	  may	  include	  Bodily	  Harm	  
or	  Physical	  Danger	  of	  the	  medical	  technology	  itself	  or	  from	  another	  
person	  e.g.	  a	  husband.	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1701.3	  Autonomy.	  This	  may	  include	  Respecting	  the	  Patient’s	  Decision,	  
Being	  Pro-­‐Choice.	  
1701.4	  Beneficence.	  This	  may	  include	  Wanting	  to	  Help	  Patients	  or	  the	  
Patient’s	  Best	  Interest.	  
	   1702	  Parenting	  Norms.	  
	   This	  is	  appropriate	  when	  a	  physician	  talks	  about	  how	  parents	  should	  or	  
should	  not	  	  
feel	  about	  or	  act	  toward	  their	  children.	  This	  can	  also	  be	  used	  when	  the	  
physician	  	  
talks	  about	  how	  parenthood	  or	  child-­‐bearing	  are	  typically	  done	  (aka	  the	  
current	  	  
norm).	  
	   1703	  Valuing	  Differences.	  
	   Variety	  is	  the	  spice	  of	  life.	  This	  can	  come	  up	  for	  NMSS	  or	  NMTS.	  
1704	  Being	  a	  Parent.	  	  
This	  is	  used	  when	  the	  participant	  talks	  about	  the	  influence	  on	  their	  beliefs	  
and	  ideas	  of	  being	  a	  parent	  themselves.	  
1705	  Gender	  Equality.	  
This	  is	  used	  when	  the	  participant	  talks	  about	  Being	  a	  Feminist,	  or	  Valuing	  
Gender	  Equality,	  or	  being	  distressed	  by	  the	  valuing	  of	  one	  sex	  over	  another.	  
1706	  Other	  Values.	  
This	  might	  include	  religious,	  cultural,	  political,	  scientific	  (e.g.	  evolution;	  
discarding	  embryos)	  or	  other	  values.	  Also	  a	  catchall	  when	  it’s	  a	  professional	  
value	  that	  doesn’t	  fit	  into	  medical	  ethics.	  
	  
1800	  Significant	  Quote	  –	  use	  whenever	  something	  is	  an	  especially	  enlightening	  




















	   82	  
APPENDIX	  H:	  INTERVIEW	  SUMMARY	  SHEET	  
	  
Date	  of	  interview:	  _____________________	  
Interview	  start	  time:	  ___________________	  
Interview	  end	  time:	  ____________________	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APPENDIX	  I:	  ALTERNATIVE	  TELEPHONE	  SCRIPTS	  
	  
For	  early	  eligible	  respondents	  and	  respondents	  with	  underrepresented	  
characteristics:	  
	  
Hello	  Dr.	  	   ,	  
Thank	  you	  for	  your	  interest	  in	  our	  study!	  We	  would	  like	  to	  welcome	  you	  to	  the	  study	  
and	  invite	  you	  to	  schedule	  your	  interview.	  We	  will	  look	  at	  our	  schedules	  to	  find	  a	  
date	  and	  time	  that	  will	  work	  for	  you.	  We	  will	  send	  you	  the	  consent	  form	  for	  this	  
study	  in	  advance	  of	  your	  telephone	  interview;	  would	  you	  prefer	  to	  have	  this	  mailed	  
or	  faxed	  to	  you?	  Thank	  you	  again	  for	  your	  interest	  and	  your	  time.	  	  	  
	  
For	  later	  or	  respondents	  with	  overrepresented	  characteristics:	  
	  
Hello	  Dr.	   ,	  
Thank	  you	  for	  your	  interest	  in	  our	  study!	  Because	  of	  the	  number	  of	  respondents,	  we	  
are	  asking	  if	  we	  can	  call	  you	  back	  by	  (date)	  to	  let	  you	  know	  if	  you	  qualify	  for	  this	  
study.	  We	  look	  forward	  to	  being	  in	  touch	  with	  you	  again	  soon.	  Thank	  you	  again	  for	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